{      
        {
        "-rank": "142",
        "nct_id": "NCT02525068",
        "title": "A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC",
        "acronym": "RE-AKT",
        "status": {
          "-open": "Y",
          "#text": "Recruiting"
        },
        "study_results": "No Results Available",
        "conditions": { "condition": "Adenocarcinoma of the Prostate" },
        "interventions": {
          "intervention": [
            {
              "-type": "Drug",
              "#text": "AZD5363"
            },
            {
              "-type": "Drug",
              "#text": "Enzalutamide"
            }
          ]
        },
        "outcome_measures": {
          "outcome_measure": [
            "Phase I: Type, frequency, severity, seriousness and relatedness of adverse events",
            "Phase I: Laboratory abnormalities will be assessed according to NCI CTCAE v4",
            "Randomised phase II: Best overall tumour response",
            "Phase II expansion: Best overall tumour response",
            "Phase I and phase II expansion only - Pharmacokinetic (PK) assay analyses",
            "Phase I - Antitumour activity of the combination",
            "Randomised phase II and phase II expansion - Overall survival and radiographic progression free survival",
            "Maximum PSA decline and circulating tumour cell (CTC) fall",
            "Pain Palliation - Randomised phase II only",
            "Number of Adverse events will be graded according to NCI-CTCAE v4"
          ]
        },
        "sponsors": {
          "lead_sponsor": "Institute of Cancer Research, United Kingdom",
          "collaborator": "Royal Marsden NHS Foundation Trust"
        },
        "gender": "Male",
        "min_age": "18 Years",
        "age_groups": {
          "age_group": [
            "Adult",
            "Older Adult"
          ]
        },
        "phases": { "phase": "Phase 2" },
        "enrollment": "136",
        "funded_bys": { "funded_by": "Other" },
        "study_types": "Interventional",
        "study_designs": {
          "study_design": [
            "Allocation: Randomized",
            "Intervention Model: Parallel Assignment",
            "Masking: Triple (Participant, Care Provider, Investigator)",
            "Primary Purpose: Treatment"
          ]
        },
        "other_ids": {
          "other_id": [
            "ICR‐CTSU/2012/10037",
            "2013-004091-34",
            "CRUKE/12/050",
            "ISRCTN17168679",
            "ISS53630011"
          ]
        },
        "start_date": "December 2014",
        "primary_completion_date": "December 31, 2019",
        "completion_date": "March 2020",
        "study_first_posted": "August 17, 2015",
        "last_update_posted": "August 8, 2018",
        "locations": { "location": "Royal Marsden Hospital, Sutton, Surrey, United Kingdom" },
        "url": "https://ClinicalTrials.gov/show/NCT02525068"
      },
      {
        "-rank": "143",
        "nct_id": "NCT03732820",
        "title": "Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer",
        "status": {
          "-open": "Y",
          "#text": "Recruiting"
        },
        "study_results": "No Results Available",
        "conditions": { "condition": "Metastatic Castration-resistant Prostate Cancer" },
        "interventions": {
          "intervention": [
            {
              "-type": "Drug",
              "#text": "olaparib"
            },
            {
              "-type": "Drug",
              "#text": "abiraterone acetate"
            }
          ]
        },
        "outcome_measures": {
          "outcome_measure": [
            "Radiological progression free survival (rPFS)",
            "Time to first subsequent anticancer therapy or death (TFST)",
            "Time to pain progression (TTPP)",
            "Overall survival (OS)",
            "Time to opiate use",
            "Time to a Symptomatic Skeletal-Related Event (SSRE)",
            "Circulating Tumour Cells (CTC) conversion",
            "Time to second progression or death (PFS2)",
            "Brief Pain Inventory-Short Form (BPI-SF)",
            "Functional Assessment of Cancer Therapy- Prostate Cancer (FACT-P)",
            "Homologous Recombination Repair (HRR) gene status",
            "Maximum plasma concentration at steady state [Cmax,ss]",
            "Time to maximum plasma concentration at steady state (Cmax,ss) [tmax,ss]",
            "Minimum plasma concentration at steady state [Cmin,ss]",
            "Partial area under the concentration-time curve in 0-8 h [AUC0-8])",
            "Partial area under the concentration-time curve [AUC0-8])",
            "Number of adverse events",
            "Vital signs-blood pressure",
            "Vital signs-pulse rate",
            "Vital signs-body temperature",
            "ECG",
            "Change in Albumin (g/L)",
            "Change in Alkaline phosphatase (U/L)",
            "Change in Aspartate aminotransferase (U/L)",
            "Change in Amylase (U/L)",
            "Change in Alanine aminotransferase (U/L)",
            "Change in Total bilirubin (μmol/L)",
            "Change in Direct bilirubin",
            "Change in Calcium (mmol/L)",
            "Change in Chloride (mmol/L)",
            "Change in Creatinine (μmol/L)",
            "Change in Gamma glutamyltransferase (U/L)",
            "Change in Fasting gucose (mmol/L)",
            "Change in Lactate dehydrogenase (U/L)",
            "Change in Magnesium (mmol/L)",
            "Change in Potassium (mmol/L)",
            "Change in Phosphorus ((mmol/L)",
            "Change in Sodium (mmol/L)",
            "Change in Carbon dioxide (mEq/L )",
            "Change in Total protein (g/L)",
            "Change in Urea or blood urea nitrogen, depending on the local practice (mmol/L)",
            "Change in absolute neutrophil count (/L)",
            "Change in absolute lymphocyte count (/L)",
            "Change in haemoglobin (g/L)",
            "Change in platelet count with differential (/L)",
            "Change in total white blood cell count with differential(/L)",
            "Change in red blood cell count (/l)",
            "Change in Haematocrit (%)",
            "Change in Mean Cell Volume (fL)",
            "Urinalysis:change in blood",
            "Urinalysis: Change in protein",
            "Urinalysis: change in glucose"
          ]
        },
        "sponsors": {
          "lead_sponsor": "AstraZeneca",
          "collaborator": "Merck Sharp & Dohme Corp."
        },
        "gender": "Male",
        "min_age": "18 Years",
        "max_age": "99 Years",
        "age_groups": {
          "age_group": [
            "Adult",
            "Older Adult"
          ]
        },
        "phases": { "phase": "Phase 3" },
        "enrollment": "720",
        "funded_bys": { "funded_by": "Industry" },
        "study_types": "Interventional",
        "study_designs": {
          "study_design": [
            "Allocation: Randomized",
            "Intervention Model: Parallel Assignment",
            "Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)",
            "Primary Purpose: Treatment"
          ]
        },
        "other_ids": {
          "other_id": [
            "D081SC00001",
            "2018-002011-10"
          ]
        },
        "start_date": "October 31, 2018",
        "primary_completion_date": "April 13, 2021",
        "completion_date": "August 17, 2022",
        "study_first_posted": "November 7, 2018",
        "last_update_posted": "August 7, 2019",
        "locations": {
          "location": [
            "Research Site, Homewood, Alabama, United States",
            "Research Site, Anchorage, Alaska, United States",
            "Research Site, Tucson, Arizona, United States",
            "Research Site, Tucson, Arizona, United States",
            "Research Site, Clovis, California, United States",
            "Research Site, La Jolla, California, United States",
            "Research Site, Los Angeles, California, United States",
            "Research Site, Los Angeles, California, United States",
            "Research Site, Sacramento, California, United States",
            "Research Site, San Diego, California, United States",
            "Research Site, Denver, Colorado, United States",
            "Research Site, Norwich, Connecticut, United States",
            "Research Site, Lisle, Illinois, United States",
            "Research Site, Jeffersonville, Indiana, United States",
            "Research Site, New Orleans, Louisiana, United States",
            "Research Site, Towson, Maryland, United States",
            "Research Site, Detroit, Michigan, United States",
            "Research Site, Grand Rapids, Michigan, United States",
            "Research Site, Saint Louis, Missouri, United States",
            "Research Site, Bozeman, Montana, United States",
            "Research Site, Omaha, Nebraska, United States",
            "Research Site, Paramus, New Jersey, United States",
            "Research Site, Brooklyn, New York, United States",
            "Research Site, Fresh Meadows, New York, United States",
            "Research Site, Lake Success, New York, United States",
            "Research Site, Mineola, New York, United States",
            "Research Site, Rochester, New York, United States",
            "Research Site, Syracuse, New York, United States",
            "Research Site, White Plains, New York, United States",
            "Research Site, Durham, North Carolina, United States",
            "Research Site, Middleburg Heights, Ohio, United States",
            "Research Site, Portland, Oregon, United States",
            "Research Site, Philadelphia, Pennsylvania, United States",
            "Research Site, Charleston, South Carolina, United States",
            "Research Site, Myrtle Beach, South Carolina, United States",
            "Research Site, San Antonio, Texas, United States",
            "Research Site, Seattle, Washington, United States",
            "Research Site, Wheeling, West Virginia, United States",
            "Research Site, Milwaukee, Wisconsin, United States",
            "Research Site, Box Hill, Australia",
            "Research Site, Darlinghurst, Australia",
            "Research Site, Greenslopes, Australia",
            "Research Site, Herston, Australia",
            "Research Site, Kingswood, Australia",
            "Research Site, Kurralta Park, Australia",
            "Research Site, St Albans, Australia",
            "Research Site, Waratah, Australia",
            "Research Site, Brussels, Belgium",
            "Research Site, Brussels, Belgium",
            "Research Site, Gent, Belgium",
            "Research Site, Liège, Belgium",
            "Research Site, Belo Horizonte, Brazil",
            "Research Site, Curitiba, Brazil",
            "Research Site, Fortaleza, Brazil",
            "Research Site, Porto Alegre, Brazil",
            "Research Site, Porto Alegre, Brazil",
            "Research Site, Rio de Janeiro, Brazil",
            "Research Site, Sao Paulo, Brazil",
            "Research Site, Sao Paulo, Brazil",
            "Research Site, São José do Rio Preto, Brazil",
            "Research Site, Calgary, Alberta, Canada",
            "Research Site, Edmonton, Alberta, Canada",
            "Research Site, Kelowna, British Columbia, Canada",
            "Research Site, Toronto, CA, Canada",
            "Research Site, Halifax, Nova Scotia, Canada",
            "Research Site, London, Ontario, Canada",
            "Research Site, Toronto, Ontario, Canada",
            "Research Site, Greenfield Park, Quebec, Canada",
            "Research Site, Montreal, Quebec, Canada",
            "Research Site, Montreal, Quebec, Canada",
            "Research Site, Santiago, Chile",
            "Research Site, Santiago, Chile",
            "Research Site, Temuco, Chile",
            "Research Site, Viña del Mar, Chile",
            "Research Site, Beijing, China",
            "Research Site, Beijing, China",
            "Research Site, Beijing, China",
            "Research Site, Beijing, China",
            "Research Site, Changsha, China",
            "Research Site, Changsha, China",
            "Research Site, Chengdu, China",
            "Research Site, ChongQing, China",
            "Research Site, Hangzhou, China",
            "Research Site, Hangzhou, China",
            "Research Site, Hangzhou, China",
            "Research Site, Nanchang, China",
            "Research Site, Nanjing, China",
            "Research Site, Shanghai, China",
            "Research Site, Shanghai, China",
            "Research Site, Shanghai, China",
            "Research Site, Xi'an, China",
            "Research Site, Xiamen, China",
            "Research Site, Brno, Czechia",
            "Research Site, Hradec Kralove, Czechia",
            "Research Site, Praha 5, Czechia",
            "Research Site, Praha, Czechia",
            "Research Site, Angers Cedex 01, France",
            "Research Site, BESANCON Cedex, France",
            "Research Site, Caen Cedex 05, France",
            "Research Site, Marseille, France",
            "Research Site, Pierre Benite, France",
            "Research Site, Quimper Cedex, France",
            "Research Site, Toulouse Cedex 3, France",
            "Research Site, Vandoeuvre les Nancy, France",
            "Research Site, Bergisch Gladbach, Germany",
            "Research Site, Bremen, Germany",
            "Research Site, Duisburg, Germany",
            "Research Site, Freiburg im Breisgau, Germany",
            "Research Site, Hannover, Germany",
            "Research Site, Heinsberg, Germany",
            "Research Site, Köln, Germany",
            "Research Site, Mettmann, Germany",
            "Research Site, Nürnberg, Germany",
            "Research Site, Nürtingen, Germany",
            "Research Site, Ulm, Germany",
            "Research Site, Milano, Italy",
            "Research Site, Milano, Italy",
            "Research Site, Napoli, Italy",
            "Research Site, Orbassano, Italy",
            "Research Site, Pavia, Italy",
            "Research Site, Roma, Italy",
            "Research Site, Trento, Italy",
            "Research Site, Bunkyo-ku, Japan",
            "Research Site, Hirakata-shi, Japan",
            "Research Site, Kashihara-shi, Japan",
            "Research Site, Kawagoe-shi, Japan",
            "Research Site, Kita-gun, Japan",
            "Research Site, Kyoto-shi, Japan",
            "Research Site, Maebashi-shi, Japan",
            "Research Site, Nagoya-shi, Japan",
            "Research Site, Osaka-shi, Japan",
            "Research Site, Osaka-shi, Japan",
            "Research Site, Osakasayama-shi, Japan",
            "Research Site, Sagamihara-shi, Japan",
            "Research Site, Sakura-shi, Japan",
            "Research Site, Shinjuku-ku, Japan",
            "Research Site, Toon-shi, Japan",
            "Research Site, Yokohama-shi, Japan",
            "Research Site, Daegu, Korea, Republic of",
            "Research Site, Goyang-si, Korea, Republic of",
            "Research Site, Seoul, Korea, Republic of",
            "Research Site, Seoul, Korea, Republic of",
            "Research Site, Seoul, Korea, Republic of",
            "Research Site, Seoul, Korea, Republic of",
            "Research Site, Hilversum, Netherlands",
            "Research Site, Nijmegen, Netherlands",
            "Research Site, Tilburg, Netherlands",
            "Research Site, Bratislava, Slovakia",
            "Research Site, Nitra, Slovakia",
            "Research Site, Presov, Slovakia",
            "Research Site, Sala, Slovakia",
            "Research Site, Trencin, Slovakia",
            "Research Site, Barcelona, Spain",
            "Research Site, Barcelona, Spain",
            "Research Site, Gerona, Spain",
            "Research Site, Madrid, Spain",
            "Research Site, Malaga, Spain",
            "Research Site, Sevilla, Spain",
            "Research Site, Adana, Turkey",
            "Research Site, Ankara, Turkey",
            "Research Site, Ankara, Turkey",
            "Research Site, Istanbul, Turkey",
            "Research Site, Izmir, Turkey",
            "Research Site, Karsiyaka, Turkey",
            "Research Site, Blackburn, United Kingdom",
            "Research Site, Guildford, United Kingdom",
            "Research Site, Manchester, United Kingdom",
            "Research Site, Sheffield, United Kingdom",
            "Research Site, Southampton, United Kingdom",
            "Research Site, Swansea, United Kingdom"
          ]
        },
        "url": "https://ClinicalTrials.gov/show/NCT03732820"
      },
      {
        "-rank": "144",
        "nct_id": "NCT00003290",
        "title": "Radiation Therapy in Treating Patients With Prostate Cancer",
        "status": {
          "-open": "N",
          "#text": "Completed"
        },
        "study_results": "No Results Available",
        "conditions": { "condition": "Prostate Cancer" },
        "interventions": {
          "intervention": [
            {
              "-type": "Biological",
              "#text": "gonadotrophin releasing hormone"
            },
            {
              "-type": "Radiation",
              "#text": "radiation therapy"
            }
          ]
        },
        "sponsors": {
          "lead_sponsor": "Medical Research Council",
          "collaborator": "National Cancer Institute (NCI)"
        },
        "gender": "Male",
        "age_groups": {
          "age_group": [
            "Child",
            "Adult",
            "Older Adult"
          ]
        },
        "phases": { "phase": "Phase 3" },
        "enrollment": "800",
        "funded_bys": { "funded_by": "Other" },
        "study_types": "Interventional",
        "study_designs": {
          "study_design": [
            "Allocation: Randomized",
            "Primary Purpose: Treatment"
          ]
        },
        "other_ids": {
          "other_id": [
            "CDR0000066222",
            "MRC-RT01",
            "EU-98005"
          ]
        },
        "start_date": "January 1998",
        "completion_date": "August 2004",
        "study_first_posted": "April 23, 2003",
        "last_update_posted": "December 4, 2013",
        "locations": {
          "location": [
            "Groote Schuur Hospital, Cape Town, Cape Town, South Africa",
            "University of Birmingham, Birmingham, England, United Kingdom",
            "Bristol Royal Hospital for Children, Bristol, England, United Kingdom",
            "Bristol Haematology and Oncology Centre, Bristol, England, United Kingdom",
            "Derbyshire Royal Infirmary, Derby, England, United Kingdom",
            "Cookridge Hospital, Leeds, England, United Kingdom",
            "University Hospitals of Leicester, Leicester, England, United Kingdom",
            "Middlesex Hospital- Meyerstein Institute, London, England, United Kingdom",
            "Christie Hospital N.H.S. Trust, Manchester, England, United Kingdom",
            "Clatterbridge Centre for Oncology NHS Trust, Merseyside, England, United Kingdom",
            "Newcastle General Hospital, Newcastle Upon Tyne, England, United Kingdom",
            "Mount Vernon Hospital, Northwood, England, United Kingdom",
            "Norfolk & Norwich Hospital, Norwich, England, United Kingdom",
            "Oxford Radcliffe Hospital, Oxford, England, United Kingdom",
            "Royal Marsden Hospital, Sutton, England, United Kingdom",
            "Southend NHS Trust Hospital, Westcliff-On-Sea, England, United Kingdom",
            "Royal Hospital for Sick Children, Edinburgh, Scotland, United Kingdom",
            "Beatson Oncology Centre, Glasgow, Scotland, United Kingdom",
            "Royal Preston Hospital, Preston, United Kingdom"
          ]
        },
        "url": "https://ClinicalTrials.gov/show/NCT00003290"
      },
      {
        "-rank": "145",
        "nct_id": "NCT01578655",
        "title": "Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer",
        "acronym": "AFFINITY",
        "status": {
          "-open": "N",
          "#text": "Completed"
        },
        "study_results": "No Results Available",
        "conditions": { "condition": "Prostate Cancer" },
        "interventions": {
          "intervention": [
            {
              "-type": "Drug",
              "#text": "cabazitaxel"
            },
            {
              "-type": "Drug",
              "#text": "prednisone"
            },
            {
              "-type": "Drug",
              "#text": "custirsen sodium"
            }
          ]
        },
        "outcome_measures": {
          "outcome_measure": [
            "Survival in the intent-to-treat population",
            "Survival in the poor-prognosis patient population",
            "Progression-free survival at Day 140"
          ]
        },
        "sponsors": { "lead_sponsor": "Achieve Life Sciences" },
        "gender": "Male",
        "age_groups": {
          "age_group": [
            "Child",
            "Adult",
            "Older Adult"
          ]
        },
        "phases": { "phase": "Phase 3" },
        "enrollment": "630",
        "funded_bys": { "funded_by": "Industry" },
        "study_types": "Interventional",
        "study_designs": {
          "study_design": [
            "Allocation: Randomized",
            "Intervention Model: Parallel Assignment",
            "Masking: None (Open Label)",
            "Primary Purpose: Treatment"
          ]
        },
        "other_ids": { "other_id": "OGX-011-12" },
        "start_date": "August 2012",
        "primary_completion_date": "July 2016",
        "completion_date": "July 2016",
        "study_first_posted": "April 17, 2012",
        "last_update_posted": "October 12, 2016",
        "locations": {
          "location": [
            "Prostate Oncology Specialists, Marina Del Rey, California, United States",
            "University of California Davis Medical Center, Sacramento, California, United States",
            "Sharp Health Care, San Diego, California, United States",
            "California Pacific Medical Center Research Institute, San Francisco, California, United States",
            "Rocky Mountain Cancer Center, Boulder, Colorado, United States",
            "Hartford Hospital, Hartford, Connecticut, United States",
            "Smilow Cancer Hospital at Yale New Haven Hospital, New Haven, Connecticut, United States",
            "The Center for Hematology-Oncology, Boca Raton, Florida, United States",
            "Florida Cancer Specialists, Fort Myers, Florida, United States",
            "Florida Cancer Specialists, Inverness, Florida, United States",
            "H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States",
            "Georgia Cancer Specialists, P.C., Marietta, Georgia, United States",
            "Cancer Center of Kansas, Wichita, Kansas, United States",
            "Boston University Medical Center, Boston, Massachusetts, United States",
            "University of Michigan Health System, Ann Arbor, Michigan, United States",
            "Karmanos Cancer Institute, Detroit, Michigan, United States",
            "Washington University School of Medicine, St. Louis, Missouri, United States",
            "Urology Cancer Center and GU Research Network, Omaha, Nebraska, United States",
            "Albert Einstein Medical Center, Bronx, New York, United States",
            "Monter Cancer Center, Lake Success, New York, United States",
            "SUNY Upstate Medical University, Syracuse, New York, United States",
            "Blumenthal Cancer Center, Charlotte, North Carolina, United States",
            "Cancer Centers of North Carolina, Raleigh, North Carolina, United States",
            "Oncology Hematology Care, Inc., Blue Ash, Ohio, United States",
            "The Mark H. Zangmeister Center, Columbus, Ohio, United States",
            "Oregon Health and Science University, Portland, Oregon, United States",
            "South Carolina Oncology Associates, Columbia, South Carolina, United States",
            "Cancer Centers of the Carolinas, Greenville, South Carolina, United States",
            "Chattanooga Oncology and Hematology Associates, Chattanooga, Tennessee, United States",
            "The West Clinic, Memphis, Tennessee, United States",
            "Tennessee Oncology, PLLC, Nashville, Tennessee, United States",
            "Texas Oncology, PA, Dallas, Texas, United States",
            "Utah Cancer Specialists, Salt Lake City, Utah, United States",
            "Virginia Oncology Associates, Norfolk, Virginia, United States",
            "Virginia Cancer Institute, Richmond, Virginia, United States",
            "The Canberra Hospital, Garran, Australian Capital Territory, Australia",
            "Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia",
            "St George Public Hospital, Kogarah, New South Wales, Australia",
            "Royal North Shore Hospital, Saint Leonards, New South Wales, Australia",
            "Westmead Hospital, Westmead, New South Wales, Australia",
            "Haematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia",
            "The Queen Elizabeth Hospital, Woodville South, South Australia, Australia",
            "Royal Hobart Hospital, Hobart, Tasmania, Australia",
            "Box Hill Hospital, Box Hill, Victoria, Australia",
            "Austin Health, Heidelberg, Victoria, Australia",
            "Epworth Healthcare, Richmond, Victoria, Australia",
            "Cross Cancer Institute, Edmonton, Alberta, Canada",
            "British Columbia Cancer Agency, Vancouver, British Columbia, Canada",
            "Juravinski Cancer Centre, Hamilton, Ontario, Canada",
            "London Health Sciences Center, London, Ontario, Canada",
            "R. S. McLaughlin Durham Regional Cancer Center at Lakeridge Health Oshawa, Oshawa, Ontario, Canada",
            "The Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada",
            "Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada",
            "CHUM-Hospital Notre-Dame, Montréal, Quebec, Canada",
            "Krajská nemo. T.Bati, a. s., Zlín, Severomoravsky Kraj, Czech Republic",
            "Fakultni nemo Hradec Králové, Hradec Králové, Czech Republic",
            "Krajská nemocnice Liberec a.s., Liberec, Czech Republic",
            "University Hospital Olomouc, Olomouc, Czech Republic",
            "Centre François Baclesse, Caen cedex 05, Basse-Normandie, France",
            "Institut Jean-Godinot, Reims, Champagne-Ardenne, France",
            "Hôpital Saint Louis, Paris, Ile de France, France",
            "Institut Curie, Paris Cedex 05, Ile-de-France, France",
            "Institut Gustave Roussy, Villejuif, Ile-de-France, France",
            "Institut de Cancérologie de l'Ouest - René Gauducheau, Saint Herblain, Pays de la Loire, France",
            "Centre Hospitalier Universitaire de Poitiers Hôpital de la Milétrie, Poitiers Cedex, Poitou-Charentes, France",
            "Centre Antoine Lacassagne, Nice Cedex 2, Provence Alpes Cote d'Azur, France",
            "Centre Léon Bérard, Lyon cédex 08, Rhone-Alpes, France",
            "Institut Paoli Calmettes, Marseille, France",
            "Pándy Kálmán Megyei Kórház, Gyula, Bekes, Hungary",
            "Borsod Abaúj Zemplén Megyei Kórház és Egyetemi Oktató Kórház, Miskolc, Borsod-Abauj-Zemplen, Hungary",
            "Szegedi Tudományegyetem, Onkoterápiás Klinika, Szeged, Csongrad, Hungary",
            "Országos Onkológiai Intézet, Budapest, Hungary",
            "Semmelweis Egyetem Általános Orvostudományi Kar, Budapest, Hungary",
            "Sverdlovsk Reg Clin Hosp#1, Ekaterinburg, Ural, Russian Federation",
            "Volgograd Regional Oncological Dispensary, Volzhskiy, Volgograd, Russian Federation",
            "S Inst Hlth Altay Reg Onc Disp, Barnaul, Russian Federation",
            "Ivanovo Reg Oncology Centre, Ivanovo, Russian Federation",
            "Cancer Research Center na NN Blokhin, Moscow, Russian Federation",
            "Hertzen Rsrch Inst of Oncology, Moscow, Russian Federation",
            "Russian Research Center of Radiology, Moscow, Russian Federation",
            "Urology Research Institute, Moscow, Russian Federation",
            "State Healthcare Inst Omsk Reg, Omsk, Russian Federation",
            "Petrov Research Oncology Institute, Saint Petersburg, Russian Federation",
            "Saint Petersburg City Oncological Dispensary, Saint Petersburg, Russian Federation",
            "Stavropol Reg Oncology Ctr, Stavropol, Russian Federation",
            "Cancer Research UK, Birmingham, England, United Kingdom",
            "Addenbrookes Hospital Cambridge, Cambridge, England, United Kingdom",
            "U of Surrey Post Grad Med, Guildford, England, United Kingdom",
            "Christie Hospital NHS Foundation Trust, Manchester, England, United Kingdom",
            "Nottingham City Hospital NHS Trust, Nottingham, England, United Kingdom",
            "The Royal Marsden Hospital, Surrey, England, United Kingdom",
            "Musgrove Park Hospital, Taunton, England, United Kingdom",
            "Clatterbridge Centre for Oncology NHS Foundation Trust, Wirral, England, United Kingdom",
            "Beatson Cancer Centre, Glasgow, Glasgow, Scotland, United Kingdom"
          ]
        },
        "url": "https://ClinicalTrials.gov/show/NCT01578655"
      },
      {
        "-rank": "146",
        "nct_id": "NCT02960022",
        "title": "A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study",
        "status": {
          "-open": "Y",
          "#text": "Recruiting"
        },
        "study_results": "No Results Available",
        "conditions": { "condition": "Prostate Cancer" },
        "interventions": {
          "intervention": [
            {
              "-type": "Drug",
              "#text": "enzalutamide"
            },
            {
              "-type": "Drug",
              "#text": "abiraterone acetate"
            },
            {
              "-type": "Drug",
              "#text": "prednisone"
            }
          ]
        },
        "outcome_measures": { "outcome_measure": "Number of participants with adverse events" },
        "sponsors": {
          "lead_sponsor": "Astellas Pharma Global Development, Inc.",
          "collaborator": [
            "Pfizer",
            "Astellas Pharma Inc"
          ]
        },
        "gender": "Male",
        "min_age": "18 Years",
        "age_groups": {
          "age_group": [
            "Adult",
            "Older Adult"
          ]
        },
        "phases": { "phase": "Phase 2" },
        "enrollment": "470",
        "funded_bys": { "funded_by": "Industry" },
        "study_types": "Interventional",
        "study_designs": {
          "study_design": [
            "Allocation: Non-Randomized",
            "Intervention Model: Parallel Assignment",
            "Masking: None (Open Label)",
            "Primary Purpose: Treatment"
          ]
        },
        "other_ids": {
          "other_id": [
            "9785-CL-0123",
            "2016-001694-32"
          ]
        },
        "start_date": "December 22, 2016",
        "primary_completion_date": "July 2021",
        "completion_date": "July 2021",
        "study_first_posted": "November 9, 2016",
        "last_update_posted": "April 8, 2019",
        "locations": {
          "location": [
            "Site US10052, Anchorage, Alaska, United States",
            "Site US10011, Tucson, Arizona, United States",
            "Site US10040, Los Angeles, California, United States",
            "Site US10009, Los Angeles, California, United States",
            "Site US10008, San Bernardino, California, United States",
            "Site US10042, San Diego, California, United States",
            "Site US10028, Stanford, California, United States",
            "Site US10001, Aurora, Colorado, United States",
            "Site US10017, Denver, Colorado, United States",
            "Site US10050, Washington, District of Columbia, United States",
            "Site US10049, Daytona Beach, Florida, United States",
            "Site US10048, Jacksonville, Florida, United States",
            "Site US10002, Chicago, Illinois, United States",
            "Site US10007, Jeffersonville, Indiana, United States",
            "Site US10029, Towson, Maryland, United States",
            "Site US10032, Saint Louis, Missouri, United States",
            "Site US10023, Omaha, Nebraska, United States",
            "Site US10004, Hackensack, New Jersey, United States",
            "Site US10024, Garden City, New York, United States",
            "Site US10055, New York, New York, United States",
            "Site US10059, New York, New York, United States",
            "Site US10053, Syracuse, New York, United States",
            "Site US10030, Chapel Hill, North Carolina, United States",
            "Site US10062, Charlotte, North Carolina, United States",
            "Site US10020, Concord, North Carolina, United States",
            "Site US10031, Greensboro, North Carolina, United States",
            "Site US10046, Winston-Salem, North Carolina, United States",
            "Site US10035, Cincinnati, Ohio, United States",
            "Site US10022, Springfield, Oregon, United States",
            "Site US10027, Lancaster, Pennsylvania, United States",
            "Site US10005, Pittsburgh, Pennsylvania, United States",
            "Site US10018, Charleston, South Carolina, United States",
            "Site US10003, Myrtle Beach, South Carolina, United States",
            "Site US10041, Nashville, Tennessee, United States",
            "Site US10010, Dallas, Texas, United States",
            "Site US10034, Houston, Texas, United States",
            "Site US10043, Houston, Texas, United States",
            "Site US10014, Norfolk, Virginia, United States",
            "Site US10015, Virginia Beach, Virginia, United States",
            "Site US10038, Seattle, Washington, United States",
            "Site US10021, Madison, Wisconsin, United States",
            "Site AR54003, Cordorba, Argentina",
            "Site AR54002, Tucuman, Argentina",
            "Site AU61001, Tweed Heads, New South Wales, Australia",
            "Site AU61006, Ashford, Australia",
            "Site AU61009, Malvern, Australia",
            "Site AU61008, South Brisbane, Australia",
            "Site AU61004, Westmead, Australia",
            "Site BE32002, Kortrijk, West-Vlaanderen, Belgium",
            "Site BE32004, Brussels, Belgium",
            "Site BE32005, Gent, Belgium",
            "Site BE32007, Hasselt, Belgium",
            "Site BE32008, Leuven, Belgium",
            "Site BE32001, Liege, Belgium",
            "Site BE32003, Turnhout, Belgium",
            "Site CA15003, Kingston, Ontario, Canada",
            "Site CA15001, Granby, Quebec, Canada",
            "Site CA15011, Montreal, Canada",
            "Site CL56004, IX Region, Chile",
            "Site CL56002, Santiago, Chile",
            "Site CL56001, Vina del Mar, Chile",
            "Site CZ42002, Olomouc, Czechia",
            "Site CZ42003, Praha 2, Czechia",
            "Site CZ42001, Praha 6, Czechia",
            "Site DK45002, Aalborg, Nordjylland, Denmark",
            "Site DK45003, Aarhus, Denmark",
            "Site DK45001, Copenhagen, Denmark",
            "Site DK45004, Herlev, Denmark",
            "Site FL35802, Tampere, Finland",
            "Site FR33008, La Roche sur Yon, France",
            "Site FR33010, Lille, France",
            "Site FR33002, Lyon Cedex 3, France",
            "Site FR33006, Nimes, France",
            "Site FR33003, Paris, France",
            "Site FR33017, Paris, France",
            "Site FR33001, Saint Herblain, France",
            "Site FR33004, Villejuif, France",
            "Site GE99501, Tbilisi, Georgia",
            "Site DE49004, Nürtingen, Baden-Württemberg, Germany",
            "Site DE49007, Waldshut-Tiengen, Baden-Württemberg, Germany",
            "Site DE49006, Mannheim, DE, Germany",
            "Site DE49001, Duisburg, NRW, Germany",
            "Site DE49010, Bonn, Germany",
            "Site DE49003, Hamburg, Germany",
            "Site DE49013, Hamburg, Germany",
            "Site IL97202, Peth Tikva, Israel",
            "Site IL97204, Ramat-Gan, Israel",
            "Site IL97203, Tzrifin Beer Yakov, Israel",
            "Site IT39001, Arezzo, Italy",
            "Site IT39004, Cremona, Italy",
            "Site IT39002, Forli, Italy",
            "Site IT39005, Roma, Italy",
            "Site KR82005, Seongnam-si, Korea, Republic of",
            "Site KR82001, Seoul, Korea, Republic of",
            "Site KR82002, Seoul, Korea, Republic of",
            "Site KR82003, Seoul, Korea, Republic of",
            "Site KR82004, Seoul, Korea, Republic of",
            "Site MD37301, Chisinau, Moldova, Republic of",
            "Site NZ64001, Hamilton, New Zealand",
            "Site PL48002, Gdansk, Poland",
            "Site PL48001, Myslowice, Poland",
            "Site PL48004, Pozman, Poland",
            "Site PL48003, Wroclaw, Poland",
            "Site RU70001, Moscow, Russian Federation",
            "Site RU70003, St. Petersburg, Russian Federation",
            "Site SK10223, Bratislava, Slovakia",
            "Site ZA27001, George, South Africa",
            "Site ES34003, Barcelona, Spain",
            "Site ES34004, Barcelona, Spain",
            "Site ES34001, Madrid, Spain",
            "Site ES34005, Pamplona, Spain",
            "Site GB44009, Bebington, United Kingdom",
            "Site GB44003, Belfast, United Kingdom",
            "Site GB44004, Bristol, United Kingdom",
            "Site GB44005, Cardiff, United Kingdom",
            "Site GB44002, Glasgow, United Kingdom",
            "Site GB44006, London, United Kingdom",
            "Site GB44007, Manchester, United Kingdom",
            "Site GB44008, Northwood, United Kingdom",
            "Site GB44001, Sutton, United Kingdom"
          ]
        },
        "url": "https://ClinicalTrials.gov/show/NCT02960022"
      },
      {
        "-rank": "147",
        "nct_id": "NCT01188187",
        "title": "Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer",
        "acronym": "SYNERGY",
        "status": {
          "-open": "N",
          "#text": "Completed"
        },
        "study_results": "No Results Available",
        "conditions": { "condition": "Prostate Cancer" },
        "interventions": {
          "intervention": [
            {
              "-type": "Drug",
              "#text": "Custirsen"
            },
            {
              "-type": "Drug",
              "#text": "Docetaxel"
            },
            {
              "-type": "Drug",
              "#text": "Prednisone"
            },
            {
              "-type": "Drug",
              "#text": "Dexamethasone"
            }
          ]
        },
        "outcome_measures": {
          "outcome_measure": [
            "Kaplan-Meier Estimates for Time to Death (Overall Survival)",
            "Percentage of Participants Who Were Alive Without Event At Day 140",
            "Percentage of Participants with Adverse Events"
          ]
        },
        "sponsors": {
          "lead_sponsor": "Achieve Life Sciences",
          "collaborator": "Teva Pharmaceutical Industries"
        },
        "gender": "Male",
        "min_age": "18 Years",
        "age_groups": {
          "age_group": [
            "Adult",
            "Older Adult"
          ]
        },
        "phases": { "phase": "Phase 3" },
        "enrollment": "1022",
        "funded_bys": { "funded_by": "Industry" },
        "study_types": "Interventional",
        "study_designs": {
          "study_design": [
            "Allocation: Randomized",
            "Intervention Model: Parallel Assignment",
            "Masking: None (Open Label)",
            "Primary Purpose: Treatment"
          ]
        },
        "other_ids": { "other_id": "OGX-011-11 TRANSFERRED" },
        "start_date": "November 2010",
        "primary_completion_date": "February 2014",
        "completion_date": "June 2014",
        "study_first_posted": "August 25, 2010",
        "last_update_posted": "October 14, 2016",
        "locations": {
          "location": [
            "Teva Investigational Site 100, Birmingham, Alabama, United States",
            "Teva Investigational Site 086, Los Angeles, California, United States",
            "Teva Investigational Site 263, Los Angeles, California, United States",
            "Teva Investigational Site 093, Marina del Rey, California, United States",
            "Teva Investigational Site 097, San Diego, California, United States",
            "Teva Investigational Site 090, Fort Collins, Colorado, United States",
            "Teva Investigational Site 106, Fort Myers, Florida, United States",
            "Teva Investigational Site 094, Port St. Lucie, Florida, United States",
            "Teva Investigational Site 096, Atlanta, Georgia, United States",
            "Teva Investigational Site 103, Baton Rough, Louisiana, United States",
            "Teva Investigational Site 098, Ann Arbor, Michigan, United States",
            "Teva Investigational Site 112, Detroit, Michigan, United States",
            "Teva Investigational Site 032, Rochester, Minnesota, United States",
            "Teva Investigational Site 204, Las Vegas, Nevada, United States",
            "Teva Investigational Site 107, Cincinnati, Ohio, United States",
            "Teva Investigational Site 266, Greensboro, South Carolina, United States",
            "Teva Investigational Site 102, Myrtle Beach, South Carolina, United States",
            "Teva Investigational Site 084, Memphis, Tennessee, United States",
            "Teva Investigational Site 101, Nashville, Tennessee, United States",
            "Teva Investigational Site 116, San Antonio, Texas, United States",
            "Teva Investigational Site 059, Tyler, Texas, United States",
            "Teva Investigational Site 063, Tyler, Texas, United States",
            "Teva Investigational Site 047, Newport, Virginia, United States",
            "Teva Investigational Site 104, Norfolk, Virginia, United States",
            "Teva Investigational Site 029, Seattle, Washington, United States",
            "Teva Investigational Site 862, Bonheiden, Belgium",
            "Teva Investigational Site 860, Brussels, Belgium",
            "Teva Investigational Site 864, Edegem, Belgium",
            "Teva Investigational Site 863, Gent, Belgium",
            "Teva Investigational Site 002, Calgary, Alberta, Canada",
            "Teva Investigational Site 023, Edmonton, Alberta, Canada",
            "Teva Investigational Site 118, Abbotsford, British Columbia, Canada",
            "Teva Investigational Site 007, Surrey, British Columbia, Canada",
            "Teva Investigational Site 001, Vancouver, British Columbia, Canada",
            "Teva Investigational Site 085, Victoria, British Columbia, Canada",
            "Teva Investigational Site 024, Winnipeg, Manitoba, Canada",
            "Teva Investigational Site 028, Halifax, Nova Scotia, Canada",
            "Teva Investigational Site 025, Hamilton, Ontario, Canada",
            "Teva Investigational Site 108, Kingston, Ontario, Canada",
            "Teva Investigational Site 091, Oshawa, Ontario, Canada",
            "Teva Investigational Site 003, Ottawa, Ontario, Canada",
            "Teva Investigational Site 004, Toronto, Ontario, Canada",
            "Teva Investigational Site 087, Toronto, Ontario, Canada",
            "Teva Investigational Site 026, Montreal, Quebec, Canada",
            "Teva Investigational Site 027, Montreal, Quebec, Canada",
            "Teva Investigational Site 551, Angers Cedex 9, France",
            "Teva Investigational Site 552, Avignon, France",
            "Teva Investigational Site 553, Grenoble, France",
            "Teva Investigational Site 555, La Roche-sur-Yon Cedex, France",
            "Teva Investigational Site 557, Marseille, France",
            "Teva Investigational Site 558, Nice Cedex 2, France",
            "Teva Investigational Site 560, Paris Cedex 05, France",
            "Teva Investigational Site 559, Paris Cedex 15, France",
            "Teva Investigational Site 561, Saint Herblain Cedex, France",
            "Teva Investigational Site 566, Saint-Brieuc Cedex, France",
            "Teva Investigational Site 562, Saint-Priest-en-Jarez Cedex, France",
            "Teva Investigational Site 563, Toulouse, France",
            "Teva Investigational Site 564, Vandoeuvre-les-Nancy Cedex, France",
            "Teva Investigational Site 550, Villejuif, France",
            "Teva Investigational Site 607, Aachen, Germany",
            "Teva Investigational Site 609, Berlin, Germany",
            "Teva Investigational Site 613, Berlin, Germany",
            "Teva Investigational Site 604, Darmstadt, Germany",
            "Teva Investigational Site 612, Dresden, Germany",
            "Teva Investigational Site 618, Greifswald, Germany",
            "Teva Investigational Site 600, Hannover, Germany",
            "Teva Investigational Site 606, Heidelberg, Germany",
            "Teva Investigational Site 615, Heinsberg, Germany",
            "Teva Investigational Site 611, Homburg/Saar, Germany",
            "Teva Investigational Site 617, Kempen, Germany",
            "Teva Investigational Site 608, Marburg, Germany",
            "Teva Investigational Site 616, Meiningen, Germany",
            "Teva Investigational Site 614, Muenchen, Germany",
            "Teva Investigational Site 601, Muenster, Germany",
            "Teva Investigational Site 602, Nuertingen, Germany",
            "Teva Investigational Site 603, Stuttgart, Germany",
            "Teva Investigational Site 610, Tuebingen, Germany",
            "Teva Investigational Site 605, Wuppertal, Germany",
            "Teva Investigational Site 691, Budapest, Hungary",
            "Teva Investigational Site 694, Budapest, Hungary",
            "Teva Investigational Site 692, Debrecen, Hungary",
            "Teva Investigational Site 697, Debrecen, Hungary",
            "Teva Investigational Site 696, Gyor, Hungary",
            "Teva Investigational Site 698, Miskolc, Hungary",
            "Teva Investigational Site 699, Nyiregyhaza, Hungary",
            "Teva Investigational Site 693, Szeged, Hungary",
            "Teva Investigational Site 695, Veszprem, Hungary",
            "Teva Investigational Site 506, Jerusalem, IL, Israel",
            "Teva Investigational Site 507, Haifa, Israel",
            "Teva Investigational Site 505, Petach Tikva, Israel",
            "Teva Investigational Site 502, Ramat Gan, Israel",
            "Teva Investigational Site 503, Tel Aviv, Israel",
            "Teva Investigational Site 501, Zrifin, Israel",
            "Teva Investigational Site 753, Arezzo, Italy",
            "Teva Investigational Site 758, Catanzaro, Italy",
            "Teva Investigational Site 760, Cesena (FC), Italy",
            "Teva Investigational Site 752, Genova, Italy",
            "Teva Investigational Site 755, Lugo (Ravenna), Italy",
            "Teva Investigational Site 759, Meldola (FC), Italy",
            "Teva Investigational Site 763, Milano, Italy",
            "Teva Investigational Site 754, Napoli, Italy",
            "Teva Investigational Site 756, Napoli, Italy",
            "Teva Investigational Site 761, Rimini, Italy",
            "Teva Investigational Site 750, Roma, Italy",
            "Teva Investigational Site 762, Roma, Italy",
            "Teva Investigational Site 764, Rozzano (MI), Italy",
            "Teva Investigational Site 765, Verona, Italy",
            "Teva Investigational Site 404, Cheongju,Chungbuk, Korea, Republic of",
            "Teva Investigational Site 401, Goyang-si Gyeonggi-do, Korea, Republic of",
            "Teva Investigational Site 400, Seoul, Korea, Republic of",
            "Teva Investigational Site 402, Seoul, Korea, Republic of",
            "Teva Investigational Site 403, Seoul, Korea, Republic of",
            "Teva Investigational Site 406, Seoul, Korea, Republic of",
            "Teva Investigational Site 405, Yangsan-si, Korea, Republic of",
            "Teva Investigational Site 851, Amsterdam, Netherlands",
            "Teva Investigational Site 852, Rotterdam, Netherlands",
            "Teva Investigational Site 853, Sittard-Geleen, Netherlands",
            "Teva Investigational Site 803, Barcelona, Spain",
            "Teva Investigational Site 808, Barcelona, Spain",
            "Teva Investigational Site 809, Barcelona, Spain",
            "Teva Investigational Site 816, Dos Hermanas, Spain",
            "Teva Investigational Site 814, El Palmar, Spain",
            "Teva Investigational Site 807, Guadalajara, Spain",
            "Teva Investigational Site 800, Madrid, Spain",
            "Teva Investigational Site 801, Madrid, Spain",
            "Teva Investigational Site 806, Madrid, Spain",
            "Teva Investigational Site 813, Madrid, Spain",
            "Teva Investigational Site 815, Manresa, Spain",
            "Teva Investigational Site 810, Murcia, Spain",
            "Teva Investigational Site 811, Palma de Mallorca, Spain",
            "Teva Investigational Site 805, Pamplona, Spain",
            "Teva Investigational Site 804, Sabadell - Barcelona, Spain",
            "Teva Investigational Site 802, Valencia, Spain",
            "Teva Investigational Site 704, Brighton, United Kingdom",
            "Teva Investigational Site 701, Cambridge, United Kingdom",
            "Teva Investigational Site 709, Coventry, United Kingdom",
            "Teva Investigational Site 705, Guildford, Surrey, United Kingdom",
            "Teva Investigational Site 703, Manchester, United Kingdom",
            "Teva Investigational Site 700, Surrey, United Kingdom",
            "Teva Investigational Site 710, Wirral, United Kingdom"
          ]
        },
        "url": "https://ClinicalTrials.gov/show/NCT01188187"
      },
      {
        "-rank": "148",
        "nct_id": "NCT00036543",
        "title": "A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer",
        "status": {
          "-open": "N",
          "#text": "Completed"
        },
        "study_results": "No Results Available",
        "conditions": { "condition": "Prostate Cancer" },
        "interventions": {
          "intervention": {
            "-type": "Drug",
            "#text": "Atrasentan"
          }
        },
        "outcome_measures": { "outcome_measure": "The primary objective of this study is to evaluate safety and efficacy as measured by time-to-disease progression" },
        "sponsors": { "lead_sponsor": "Abbott" },
        "gender": "Male",
        "min_age": "19 Years",
        "age_groups": {
          "age_group": [
            "Adult",
            "Older Adult"
          ]
        },
        "phases": { "phase": "Phase 3" },
        "enrollment": "1000",
        "funded_bys": { "funded_by": "Industry" },
        "study_types": "Interventional",
        "study_designs": {
          "study_design": [
            "Allocation: Randomized",
            "Intervention Model: Parallel Assignment",
            "Masking: Double",
            "Primary Purpose: Treatment"
          ]
        },
        "other_ids": { "other_id": "M00-211" },
        "start_date": "May 2001",
        "study_first_posted": "May 13, 2002",
        "last_update_posted": "August 15, 2006",
        "locations": {
          "location": [
            "Urology Centers Of Alabama, Homewood,, Alabama, United States",
            "Alaska Clinical Research Center, LLC, Anchorage, Alaska, United States",
            "Advanced Clinical Trials, Tucson, Arizona, United States",
            "Arkansas Urologial Associates, PA, Little Rock, Arkansas, United States",
            "Robin V. Smith, MD, Chula Vista, California, United States",
            "Urology Associate Of Central California, Fresno,, California, United States",
            "South Valley Medical Plaza, Gilroy, California, United States",
            "San Diego Urology Center, La Mesa, California, United States",
            "UCLA School Of Medicine, Los Angeles,, California, United States",
            "UCLA School of Medicine, Los Angeles, California, United States",
            "Hillcrest Urological Medical Group, Inc., San Diego, California, United States",
            "Urology Associates Of San Luis Obispo, San Luis Obispo,, California, United States",
            "Pacific Clinical Research, Santa Monica, California, United States",
            "Western Clinical Research, Inc., Torrance,, California, United States",
            "Urology Associate, Pc, Denver,, Colorado, United States",
            "South Fl Medical Research, Aventura, Florida, United States",
            "Clinical Physiology Associates, Fort Myers, Florida, United States",
            "Advanced Research Institute, New Port Richey, Florida, United States",
            "Urology Treatment Center, Sarasota,, Florida, United States",
            "Southeastern Urological Center, P.A., Tallahassee, Florida, United States",
            "Winship Cancer Institute Emory University, Atlanta,, Georgia, United States",
            "Sandy Springs Urology, Atlanta, Georgia, United States",
            "Atlanta Va Medical Center, Decatur, Georgia, United States",
            "Dreyer Medical Clinic, Aurora, Illinois, United States",
            "Weiss Memorial Hospital, Chicago,, Illinois, United States",
            "Progressive Care, S.C., Chicago, Illinois, United States",
            "Evanston Hospital Kellogg Cancer Center, Evanston, Illinois, United States",
            "Welborn Clinic, Evansville, Indiana, United States",
            "Urologic Associates, Pc, Davenport, Iowa, United States",
            "Iowa Urology, Des Moines, Iowa, United States",
            "Kansas University Medical Center, Kansas City,, Kansas, United States",
            "Ochsner Clinic, Department of Urology, New Orleans, Louisiana, United States",
            "Regional Urology, Shreveport, Louisiana, United States",
            "LSUHSC, Shreveport, Louisiana, United States",
            "Johns Hopkins Oncology Center, Baltimore, Maryland, United States",
            "Mid Atlantic Clinical Research, Rockville, Maryland, United States",
            "Michigan Institute Of Urology, Pc, St. Clair Shores, Michigan, United States",
            "Lakeside Urology, PC, St. Joseph, Michigan, United States",
            "Mayo Clinic, Rochester, Minnesota, United States",
            "The Medical Oncology Group, Gulfport,, Mississippi, United States",
            "St. Joseph Oncology, St. Joseph, Missouri, United States",
            "Washington University, St. Louis, Missouri, United States",
            "Billings Oncology Associates, Billings,, Montana, United States",
            "Nevada Urology Associate, Reno, Nevada, United States",
            "Albany Medical Center South Clinical Campus, Albany, New York, United States",
            "Albert Einstein College of Medicine, Bronx, New York, United States",
            "HemOnCare, PC, Brooklyn, New York, United States",
            "Beth Israel Medical Center, New York, New York, United States",
            "NYU Medical Center, New York, New York, United States",
            "Nyack Hospital, Nyack, New York, United States",
            "Rochester General Hospital, Rochester, New York, United States",
            "St. Vincent's Medical Center - Staten Island, Staten Island,, New York, United States",
            "The University Of North Carolina At Chapel Hill, Chapel Hill, North Carolina, United States",
            "Blumenthal Cancer Center, Charlotte, North Carolina, United States",
            "The Urology Center, Greensboro,, North Carolina, United States",
            "Urologic Specialists Of Oklahoma, Inc., Tulsa,, Oklahoma, United States",
            "Oregon Urology Specialists, Eugene, Oregon, United States",
            "Urologic Associates of Allentown, Allentown, Pennsylvania, United States",
            "Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States",
            "Urological Associates Of Lancaster, Lancaster, Pennsylvania, United States",
            "Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States",
            "University Of Pittsburgh, Pittsburgh, Pennsylvania, United States",
            "Center for Urologic Care, West Reading,, Pennsylvania, United States",
            "Vanderbilt University Medical Center, Nashville,, Tennessee, United States",
            "Urology Associates, Nashville, Tennessee, United States",
            "Dept of Veteran's Affairs North Texas Healthcare System, Dallas, Texas, United States",
            "Ntouch Research Corporation, Dallas, Texas, United States",
            "Uthscsa, San Antonio, Texas, United States",
            "Scott & White Memorial Hospital, Temple,, Texas, United States",
            "Anthony Middleton, M.D., Salt Lake City,, Utah, United States",
            "Western Urological Clinic, Salt Lake City, Utah, United States",
            "University Of Vermont, Burlington,, Vermont, United States",
            "Virginia Urology Center, Richmond,, Virginia, United States",
            "Jeffrey Frankel, M.D., Seattle,, Washington, United States",
            "Seattle Urological Associates, Seattle, Washington, United States",
            "University Of Washington School Of Medicine, Seattle, Washington, United States",
            "Madigan Army Medical Center, Tacoma,, Washington, United States",
            "Midwest Research Specialists, LLC, Milwaukee, Wisconsin, United States",
            "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
            "Wyoming Research Foundation, Cheyenne, Wyoming, United States",
            "St Vincent's Clinic, Darlinghurst, New South Wales, Australia",
            "Prince Of Wales Hospital, Randwick, New South Wales, Australia",
            "Westmead Public Hospital, Westmead, New South Wales, Australia",
            "Royal Brisbane Hospital, Herston, Queensland, Australia",
            "Repatriation General Hospital, Daws Park, South Australia, Australia",
            "Peter Maccallum Cancer Institute, East Melbourne, Victoria, Australia",
            "Bayside Urology, Mentone, Victoria, Australia",
            "Royal Melbourne Hospital, Parkville, Victoria, Australia",
            "Hollywood Specialist Centre, Nedlands, Western Australia, Australia",
            "Princess Alexandra Hospital, Woolloongabba, Australia",
            "Universitatsklinik Innsbruck, Innsbruck, Austria",
            "Urologische Abteilung, Linz, Austria",
            "Landesklinik fur Urologie und Andrologie, Salzburg, Austria",
            "A.Z. Middelheim, Antwerpen, Belgium",
            "AZ Middelheim, Antwerpen, Belgium",
            "A Z St Jan, Brugge, Belgium",
            "University Hospital Erasme, Bruxelles, Belgium",
            "Uz Gent, Gent, Belgium",
            "Virga Jesse Hospital, Hasselt, Belgium",
            "C.H.U. Liege, Liege, Belgium",
            "St-Elisabeth Ziekenhuis, Turnhout, Belgium",
            "Tom Baker Cancer Center, Calgary,, Alberta, Canada",
            "Cross Cancer Institute, Edmonton,, Alberta, Canada",
            "Wilson Urology, Kelowna, British Columbia, Canada",
            "Dr. Cal Andreou, Surrey, British Columbia, Canada",
            "Vancouver Hospital & Health Sciences Centre, Vancouver, British Columbia, Canada",
            "Dr. P. J. Pommerville, Inc., Victoria, British Columbia, Canada",
            "Dr. Gary Steinhoff, Clinical Research, Victoria, British Columbia, Canada",
            "Abbott Clinic, Winnipeg, Manitoba, Canada",
            "Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia, Canada",
            "Valley Professional Centre, Kentville, Nova Scotia, Canada",
            "The Male Health Centres, Barrie, Ontario, Canada",
            "Burlington Professional Centre, Burlington, Ontario, Canada",
            "The Urology Resource Centre, Burlington, Ontario, Canada",
            "Kingston General Hospital, Kingston, Ontario, Canada",
            "Probidity Medical Research, Kitchener, Ontario, Canada",
            "London Health Sciences Centre, London, Ontario, Canada",
            "Quest Clinical Trials, Markham, Ontario, Canada",
            "Walk-In Clinic, North Bay, Ontario, Canada",
            "Jack Barkin, M.D., North York, Ontario, Canada",
            "The Male Health Centres, Oakville, Ontario, Canada",
            "Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada",
            "Service Radio-Oncologie, Chus, Fleurimont,, Quebec, Canada",
            "Hopital Notre-Dame, Montreal, Quebec, Canada",
            "Royal Victoria Hospital, Montreal, Quebec, Canada",
            "Ultramed, Pointe Claire, Quebec, Canada",
            "Chuq Pavillon Hotel-Dieu, Quebec, Canada",
            "Hopital De Pontchaillou, Rennes, Cedex, France",
            "Hopital De Rangueil, Toulouse, Cedex, France",
            "CHU Hôpital Côte De Nacre, Caen, France",
            "Hôpital Henri Mondor, Creteil, France",
            "CHU de Bicêtre, Kremlin Bicetre, France",
            "Hopital Bichat Claude Bernard, Paris, France",
            "Hôpital Foch, Suresnes, France",
            "Krankenhaus Am Urban, Berlin, Germany",
            "Allgemeines Krankenhaus Urologie, Celle, Germany",
            "Universitätsklinikum Carl Gustav Carus an der, Dresden, Germany",
            "Universitätsklinikum Urologie, Essen, Germany",
            "Universitätsklinkum, Freiburg, Germany",
            "Allgemeines Krankenhaus Barmbek, Hamburg, Germany",
            "Klinik Und Poliklinik für Urologie und Kinder, Homburg / Saar, Germany",
            "Universitutsklinikum Lubeck Urologie, LuBECK, Germany",
            "Universitätsklinikum Mannheim, Mannheim, Germany",
            "Urologische Klinik Und Poliklinik Grosshadern, Munchen, Germany",
            "Klinikum Rechts Der Isar, Munchen, Germany",
            "Universitätsklinikum, Munster, Germany",
            "Städtische Kliniken, Urologie, Offenbach, Germany",
            "Universitat Ulm, ULM, Germany",
            "Klinikum Wuppertal GmbH, Wuppertal, Germany",
            "'Alexandra' Hospital, Athens, Greece",
            "Pe.Pa.G.N.I Hospital, Heraklion, Greece",
            "G. Genimatas Hospital, Thessaloniki, Greece",
            "Tallaght Hospital, Dublin, Ireland",
            "St Vincent'S Hospital, Dublin, Ireland",
            "Mater Misericordiae Hospital, Dublin, Ireland",
            "Clinica Urologica I - Università di Bari, Bari, Italy",
            "Istituto Nazionale per la Ricerca sul Cancro -IST, Genoa, Italy",
            "Istituto Europeo di Oncologia, Milan, Italy",
            "Clinica Urologica - Università Di Milano, Milan, Italy",
            "Istituto di Urologia, Padova, Italy",
            "Policlinico G. B. Rossi, Verona, Italy",
            "Amc, Amsterdam, Netherlands",
            "Rijnstate Hospital, Arnhem, Netherlands",
            "Medisch Spectrun Twente, Enschede, Netherlands",
            "Atrium Heerlen, Heerlen, Netherlands",
            "University Hospital Maastricht, Maastricht, Netherlands",
            "University Hospital Rotterdam, Rotterdam, Netherlands",
            "St Franciscus Gasthuis, Rotterdam, Netherlands",
            "University Hospital Utrecht, Utrecht, Netherlands",
            "Canterbury Urology Research Trust, Christchurch, New Zealand",
            "Promed Urology Ltd., Tauranga, New Zealand",
            "Katedra I Klinika Urologi AM, Gdansk, Poland",
            "Katedra i Klinika Urologii - Akademia Medyczna w Gdansku, Gdansk, Poland",
            "Samodzielny Publiczny Zaklad Opieki, Katowice, Poland",
            "Szpital Kliniczny Dzieciatka Jezus, Warszawa, Poland",
            "Akademia Medyczna we Wroclawiu, Wroclaw, Poland",
            "Mediclinic Hospital, Petermaritzburg, 3201, South Africa",
            "Constantiaberg Medi-Clinic, Cape Town, South Africa",
            "University Of Stellenbosch, Cape Town, South Africa",
            "University Of Natal - Nelson R Mandela School of Medicine, Durban, South Africa",
            "Kenridge St Joseph Wingl, Parktown, South Africa",
            "Medi-Clinic Hospital, Pietermaritzburg, South Africa",
            "Medical Centre, Pietermaritzburg, South Africa",
            "Pretoria Urology Hospital, Pretoria, South Africa",
            "Pretoria Academic Hospital, Pretoria, South Africa",
            "Fundacion Puigvert, Barcelona, Spain",
            "Hospital Vall D'Hebron, Barcelona, Spain",
            "Hospital de Galdakao, Galdakao-Vizcaya, Spain",
            "Hospital Juan Canalejo, La Coruna, Spain",
            "Hospital Gregorio Maranon, Madrid, Spain",
            "Clinica Puerta De Hierro, Madrid, Spain",
            "Hospital 12 De Octubre, Madrid, Spain",
            "Hospital Carlos Haya, Malaga, Spain",
            "Hospital Marques De Valdecilla, Santander, Spain",
            "Instituto Valenciano De Oncologia, Valencia, Spain",
            "Sahlgrenska University Hospital, Gothenburg, Sweden",
            "Helsingborg Hospital, Helsingborg, Sweden",
            "Linkoping University Hospital, Linkoping, Sweden",
            "Lund University Hospital, Lund, Sweden",
            "Malmo University Hospital MAS, Malmo, Sweden",
            "Orebro Regional Hospital, Orebro, Sweden",
            "Karolinska Hospital, Stockholm, Sweden",
            "Umea University Hospital, Umea, Sweden",
            "Uppsala University Hospital, Uppsala, Sweden",
            "Zentrum fur Onkologie, Hämatologie und, Aarau, Switzerland",
            "Inselspital, Universität Bern, Bern, Switzerland",
            "Chefarzt Urologische Klinik - Universitätsspital Zürich, Zürich, Switzerland",
            "Royal Devon And Exeter Hospital, Exeter,, Devon, United Kingdom",
            "Lister Hospital, Stevenage, Hertfordshire, United Kingdom",
            "Northwick Park Hospital, Harrow, Middlesex, United Kingdom",
            "Western General Hospital, Edinburgh,, Scotland, United Kingdom",
            "Taunton And Somerset Hospital, Taunton, Somerset, United Kingdom",
            "The Institute Of Cancer Research - Royal Marsden Hospital, Sutton, Surrey, United Kingdom",
            "St Lukes Hospital, Bradford, West Yorkshire, United Kingdom",
            "Clatterbridge Centre For Oncology, Bebington, Wirral, United Kingdom",
            "Aberdeen Royal Infirmary, Aberdeen, United Kingdom",
            "Institute Of Cancer Studies - University of Birmingham, Birmingham, United Kingdom",
            "Royal Sussex County Hospital, Brighton, United Kingdom",
            "Southmead Hospital, Bristol, United Kingdom",
            "Addenbrookes Hospital, Cambridge, United Kingdom",
            "St Richard'S Hospital, Chichester, United Kingdom",
            "Leighton Hospital, Crewe, United Kingdom",
            "Gartnavel General Hospital, Glasgow, United Kingdom",
            "Glasgow Royal Infirmary, Glasgow, United Kingdom",
            "Freeman Hospital, High Heaton, United Kingdom",
            "St Batholomew'S Hospital, London, United Kingdom",
            "Royal Free Hospital, London, United Kingdom",
            "Clinical Research Centre - St Georges Hospital, London, United Kingdom",
            "Nottingham City Hospital, Nottingham, United Kingdom",
            "Derriford Hospital, Plymouth, United Kingdom",
            "Hope Hospital, Salford, United Kingdom",
            "Royal Hallamshire Hospital, Sheffield, United Kingdom",
            "Southampton General, Southampton, United Kingdom"
          ]
        },
        "url": "https://ClinicalTrials.gov/show/NCT00036543"
      },
      {
        "-rank": "149",
        "nct_id": "NCT00988208",
        "title": "Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer",
        "acronym": "Mainsail",
        "status": {
          "-open": "N",
          "#text": "Completed"
        },
        "study_results": "Has Results",
        "conditions": { "condition": "Prostate Cancer" },
        "interventions": {
          "intervention": [
            {
              "-type": "Drug",
              "#text": "Lenalidomide"
            },
            {
              "-type": "Drug",
              "#text": "Docetaxel"
            },
            {
              "-type": "Drug",
              "#text": "Prednisone"
            },
            {
              "-type": "Drug",
              "#text": "Placebo"
            }
          ]
        },
        "outcome_measures": {
          "outcome_measure": [
            "Overall Survival (OS)",
            "Progression-Free Survival (PFS)",
            "Percentage of Participants With an Objective Response According to Response Evaluation Criteria in Solid Tumors - RECIST Version 1.1 Criteria",
            "Number of Participants With Treatment Emergent Adverse Events (AEs)",
            "Percentage of Participants Who Received Post-Study Therapies",
            "Percentage of Participants With Secondary Primary Malignancies During the Course of the Trial",
            "Time to Onset of Secondary Primary Malignancies"
          ]
        },
        "sponsors": { "lead_sponsor": "Celgene" },
        "gender": "Male",
        "min_age": "18 Years",
        "age_groups": {
          "age_group": [
            "Adult",
            "Older Adult"
          ]
        },
        "phases": { "phase": "Phase 3" },
        "enrollment": "1059",
        "funded_bys": { "funded_by": "Industry" },
        "study_types": "Interventional",
        "study_designs": {
          "study_design": [
            "Allocation: Randomized",
            "Intervention Model: Parallel Assignment",
            "Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)",
            "Primary Purpose: Treatment"
          ]
        },
        "other_ids": {
          "other_id": [
            "CC-5013-PC-002",
            "EudraCT Number 2008-007969-23"
          ]
        },
        "start_date": "November 11, 2009",
        "primary_completion_date": "January 13, 2012",
        "completion_date": "November 28, 2016",
        "study_first_posted": "October 2, 2009",
        "results_first_posted": "September 5, 2013",
        "last_update_posted": "April 4, 2018",
        "locations": {
          "location": [
            "Hematology Oncology Associates, Phoenix, Arizona, United States",
            "Northern AZ Hematology and Oncology Assoc, Sedona, Arizona, United States",
            "Arizona Oncology, Tucson, Arizona, United States",
            "City of Hope Cancer Center, Duarte, California, United States",
            "Southwest Cancer Center - Escondido, Escondido, California, United States",
            "Scripps Cancer Center - Clinical Research, La Jolla, California, United States",
            "VA Long Beach Healthcare System, Long Beach, California, United States",
            "The Angeles Clinc and Research Institute, Los Angeles, California, United States",
            "University of Southern California, Los Angeles, California, United States",
            "Prostate Oncology Specialists, Marina Del Rey, California, United States",
            "Stanford University Medical Center, Stanford, California, United States",
            "Rocky Mountain Cancer Centers-Colorado Springs Circle, Colorado Springs, Colorado, United States",
            "Washington Cancer Institute, Washington, District of Columbia, United States",
            "Melbourne Internal Medicine Associates, Melbourne, Florida, United States",
            "Advanced Medical Specialties, Miami, Florida, United States",
            "Florida Cancer Institute - New Hope, New Port Richey, Florida, United States",
            "Ocala Oncology Center, Ocala, Florida, United States",
            "Cancer Centers of Florida, P.A.- West Gore Street, Orlando, Florida, United States",
            "South Florida Oncology - Hematology, Tamarac, Florida, United States",
            "Palm Beach Cancer Institute, LLC, West Palm Beach, Florida, United States",
            "Cancer Care and Hematology Specialists of Chicagoland, Niles, Illinois, United States",
            "Lutheran General Hospital, Park Ridge, Illinois, United States",
            "Indiana University Health, Indianapolis, Indiana, United States",
            "Hematology and Oncology Specialist, LLC, Metairie, Louisiana, United States",
            "Maryland Oncology Hematology PA, Columbia, Maryland, United States",
            "Minnesota Oncology Hematology, PA, Minneapolis, Minnesota, United States",
            "Missouri Cancer Associates, Columbia, Missouri, United States",
            "Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States",
            "Summit Medical Group Overlook Oncology Center, Berkeley Heights, New Jersey, United States",
            "Hematology-Oncology Associates of NNJ, P, Morristown, New Jersey, United States",
            "Hematology Oncology Associates of South Jersey, Mount Holly, New Jersey, United States",
            "New York Oncology Hematology P.C., Albany, New York, United States",
            "Columbia Univ Medical Center, New York, New York, United States",
            "Weill Cornell Medical College Dr. Feldman's Office, New York, New York, United States",
            "New Bern Cancer Care, New Bern, North Carolina, United States",
            "Cancer Centers of North Carolina, Raleigh, North Carolina, United States",
            "Mid Dakota Clinic, PC, Bismarck, North Dakota, United States",
            "Oncology Hematology Care, Inc., Cincinnati, Ohio, United States",
            "Northwest Cancer Specialists-Tualatin, Tualatin, Oregon, United States",
            "Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States",
            "South Carolina Oncology Associates, PA, Columbia, South Carolina, United States",
            "Cancer Center of the Carolinas, Greer, South Carolina, United States",
            "Chattanooga Oncology Hematology Associates, Chattanooga, Tennessee, United States",
            "Cookeville Regional Medical Center, Cookeville, Tennessee, United States",
            "Sarah Cannon Research Institute UK, Nashville, Tennessee, United States",
            "Texas Oncology, P.A.-Amarillo, Amarillo, Texas, United States",
            "Texas Oncology-Arlington South, Arlington, Texas, United States",
            "Texas Oncology, PA, Austin, Texas, United States",
            "Baylor Sammons Cancer Center, Dallas, Texas, United States",
            "Texas Oncology, P.A.-Fort Worth, Fort Worth, Texas, United States",
            "Longview Cancer Center, Longview, Texas, United States",
            "Allison Cancer Center, Midland, Texas, United States",
            "Texas Oncology, P.A. - Paris, Paris, Texas, United States",
            "Southlake Oncology, Southlake, Texas, United States",
            "Texas Oncology, P.A. - Tyler, Tyler, Texas, United States",
            "Texas Oncology Deke Slayton Cancer Center, Webster, Texas, United States",
            "Texas Oncology-Texoma Cancer Center, Wichita Falls, Texas, United States",
            "Veterans Education and Research Association of Northern New England, Inc., White River Junction, Vermont, United States",
            "Cancer Outreach Associates, Abingdon, Virginia, United States",
            "Fairfax Northern Virginia Hematology Oncology, Fairfax, Virginia, United States",
            "Virginia Oncology Associates, Norfolk, Virginia, United States",
            "Virginia Cancer Institute, Richmond, Virginia, United States",
            "Oncology and Hematology Associates of Southwest Virginia, Inc., Roanoke, Virginia, United States",
            "Columbia Basin Hematology and Oncology, Kennewick, Washington, United States",
            "VA Puget Sound HCS Seattle Division, Seattle, Washington, United States",
            "Evergreen Hematology and Oncology, Spokane, Washington, United States",
            "Royal Adelaide Hospital, Adelaide, South Australia, Australia",
            "Royal Melbourne Hospital, Parkville, Victoria, Australia",
            "Flinders Medical Centre, Bedford Park, Australia",
            "Chris O'Brien Lifehouse, Camperdown, Australia",
            "Sir Charles Gairdner Hospital, Nedlands, Australia",
            "Port Macquarie Base Hospital, Port Macquarie, Australia",
            "Redcliffe Hospital, Redcliffe, Australia",
            "Royal North Shore Hospital, St Leonards, Australia",
            "Newcastle Calvary Mater Hospital, Waratah, Australia",
            "Westmead Hospital, Westmead, Australia",
            "Border Medical Oncology, Wodonga, Australia",
            "The Queen Elizabeth Hospital, Woodville South, Australia",
            "Princess Alexandra Hospital, Woolloongabba, Australia",
            "Medical University of Graz, Graz, Austria",
            "Landeskrankenhaus Salzburg, Salzburg, Austria",
            "Krankenhaus der Barmherzigen Brueder, Vienna, Austria",
            "Medizinische Universitat Wien, Vienna, Austria",
            "ZNA Middelheim, Antwerpen, Belgium",
            "Hopital Erasme, Brussels, Belgium",
            "Edith Cavell Clinic, Bruxelles, Belgium",
            "AZ Groeninge, Kortrijk, Belgium",
            "UZ Leuven, Leuven, Belgium",
            "AZ Nikolaas, Sint-Niklaas, Belgium",
            "The Health Institute for Men CMX Research Inc, Toronto, Ontario, Canada",
            "Les Urologues Specialises, Montreal, Quebec, Canada",
            "Krajska zdravotni, a.s. Nemocnice Chomutov, o.z., Chomutov, Czechia",
            "Fakultni nemocnice Motol, Prague 5, Czechia",
            "Krajska zdravotni, a.s. - Masarykova nemocnice v Usti nad La, Usti Nad Labem, Czechia",
            "Arhus Universitets hospital, Aarhus C, Denmark",
            "Herlev Hospital, Herlev, Denmark",
            "Rigshospitalet University Hospital, Kobenhavn, Denmark",
            "Odense Universitetshospital, Odense C, Denmark",
            "CRLCC Paul Papin, Angers 49, France",
            "Institut Bergonie Centre Regional de Lutte Contre Le Cancer de Bordeaux Et Sud Ouest, Bordeaux, France",
            "Centre Georges Francois Leclerc, Dijon Cedex, France",
            "Clinique Victor Hugo, Le Mans, France",
            "Centre Oscar Lambret, Lille 59, France",
            "Centre Leon Berard, Lyon, France",
            "Clinique de Valdegour, Nimes, France",
            "CHU de Poitiers, Poitiers Cedex, France",
            "Centre Eugene Marquis, Rennes Cedex, France",
            "CRLCC Centre Rene Gauducheau, Saint Herblain 44, France",
            "Institut de Cancerologie de la Loire, Saint Priest En Jaroz, France",
            "Hopital Civil de Strasbourg, Strasbourg, France",
            "CHRU Hopital Bretonneau, Tours Cedex, France",
            "Institut Gustave Roussy, Villejuif, France",
            "Vivantes Klinikum am Urban, Berlin, Germany",
            "Medizinisches Zentrum Bonn-Friedensplatz, Bonn, Germany",
            "Diakonissenkrankenhaus Dessau gGmbH, Dessau-Rosslau, Germany",
            "Universitaetsklinikum Duesseldorf, Duesseldorf, Germany",
            "Krankenhaus Nordwest, Frankfurt a.M., Germany",
            "Onkologische Praxis Freiburg, Freiburg, Germany",
            "Universitatsklinikum Hamburg-Eppendorf / IVDP, Hamburg, Germany",
            "IORC- Innovation Onkologie Research and Consulting GmbH, Hamburg, Germany",
            "Praxis fuer Haematologie und Onkologie Koblenz, Koblenz, Germany",
            "Vituro GmbH & Co KG, Leipzig, Germany",
            "TU München - Klinikum rechts der Isar, München, Germany",
            "Universitaetsklinikum Muenster, Münster, Germany",
            "University-Hospital Tübingen, Tuebingen, Germany",
            "Universitatsklinikum Ulm, Ulm, Germany",
            "Alexandra General Hospital of Athens, Athens, Greece",
            "Agioi Anargyroi Hospital, Athens, Greece",
            "University Hospital of Larissa, Larissa, Greece",
            "Papageorgiou General Hospital of Thessaloniki, Thessaloniki, Greece",
            "Fovarosi Onkirmanyzat Peterfy S.Utcai Korhaz-Rend.Int es Baleseti Kozp., Budapest, Hungary",
            "Fovarosi Onkormanyzat Bajcsy-Zsilinszky Korhaz es Rendelointezet, Budapest, Hungary",
            "Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz, Miskolc, Hungary",
            "Pecsi Tudomanyegytem Altalanos Orvostudomanyi Kar, Pecs, Hungary",
            "The Soroka University Medical Center, Beer Sheva, Israel",
            "Rambam Health Care Campus, Haifa, Israel",
            "Rabin Medical Center, Petach Tikva, Israel",
            "Assaf Harofeh Medical Center, Zerifin, Israel",
            "Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Bari, Italy",
            "Ordine Mauriziano, Candiolo, Italy",
            "Azienda Ospedaliera Istituti Ospitalieri di Cremona, Cremona, Italy",
            "Ospedale Vito Fazzi, Lecce, Italy",
            "Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori (I.R.S.T.), Meldola, Italy",
            "Ospedale di Mirano, Mirano (VE), Italy",
            "Azienda Ospedaliero Universitaria Pisana, Pisa, Italy",
            "Ospedale degli Infermi di Rimini, Rimini, Italy",
            "Azienda Ospedaliera San Camillo Forlanini, Roma, Italy",
            "Azienda Ospedaliero-Universitaria Santa Maria della Miserico, Udine, Italy",
            "Hospital Angeles Lindavista, D.f, Df, Mexico",
            "Consultorio de Especialidad en Urologia Privado, Durango, DGO, Mexico",
            "Hospital Fatima, Sinaloa, SIN, Mexico",
            "Consultorio Privado- Dr Jose Arturo Rodriguez Rivera, Zapopan, JAL, Mexico",
            "VU University Medical Center VU Medisch Centrum, Amsterdam, Netherlands",
            "Ziekenhuis Rijnstate, Arhem, Netherlands",
            "Amphia Ziekenhuis Molengracht, Breda, Netherlands",
            "HagaZiekenhuis, Den Haag, Netherlands",
            "Gemini Ziekenhuis, Den Helder, Netherlands",
            "Albert Schweitzer Ziekenhuis Amstelwijck, Dordrecht, Netherlands",
            "Catharina Ziekenhuis, Eindhoven, Netherlands",
            "Medisch Centrum Leeuwarden, Leeuwarden, Netherlands",
            "Leids Universitair Medisch Centrum, Leiden, Netherlands",
            "Academisch Ziekenhuis Maastricht, Maastricht, Netherlands",
            "St. Antonius Ziekenhuis Nieuwegein, Nieuwegein, Netherlands",
            "Erasmus Medical Center, Rotterdam, Netherlands",
            "Erasmus Medisch Centrum, Rotterdam, Netherlands",
            "Twee Steden Ziekenhuis Tilburg, Tilburg, Netherlands",
            "VieCuri Medisch Centrum Venlo, Venlo, Netherlands",
            "Isala Klinieken, Zwolle, Netherlands",
            "Uniwersyteckie Centrum Kliniczne, Gdansk, Poland",
            "Regionalny Osrodek Onkologiczny WSS im. M. Kopernika, Lodz, Poland",
            "ZOZ MSWiA z Warminsko- Mazurskim Centrum Onkologii, Olsztyn, Poland",
            "NZOZ Olsztynski Osr. Onkologiczny Kopernik Sp.z o.o, Olsztyn, Poland",
            "SPZOZ Wojewodzki Szpital Specjalistyczny nr 3 w Rybniku, Rybnik, Poland",
            "Centrum Onkologii-Instytut im.Marii Sklodowskiej-Curie, Warszawa, Poland",
            "4 Wojskowy Szpital Kliniczny z Poliklinika SP ZOZ, Wroclaw, Poland",
            "Moscow Oncology Clinical Dispensary 1, Moscow, Russian Federation",
            "Medical Radiology Research Centre RAMS, Obninsk, Russian Federation",
            "State Institution of Heath Omsk Regional Oncology Dispensary, Omsk, Russian Federation",
            "Russian Scientific Center for Radiology and Surgical Technol, St. Petersburg, Pesochny Vlg Saint Petersburg, Russian Federation",
            "NSHI Dorozhnaya Clinical Hospital of OAO Russian Railways, Rostov-on-Don, Russian Federation",
            "Oncology Dispensary 2 of Krasnodar Region, Sochi, Russian Federation",
            "Yaroslavl Regional Clinical Oncology Hospital, Yaroslavl, Russian Federation",
            "Groote Schuur Hospital, Cape Town, W Cape, South Africa",
            "The Oncology Centre Durban, Durban, KZ-Natal, South Africa",
            "Westridge Medical Centre, Durban, KZ-Natal, South Africa",
            "Netcare Oncology and Interventional Centre, Goodwood, W Cape, South Africa",
            "Dr. H. Malan, Polokwane, South Africa",
            "Pretoria Urology Hospital, Pretoria, South Africa",
            "Hospital del Mar, Barcelona, Spain",
            "Hospital Durán i Reynals - Instituto Catalàn de Oncologìa ICO, Hospitalet de Llobregat, Barcelona, Spain",
            "Hospital Arnau de Vilanova, Lérida, Spain",
            "Hospital 12 de Octobre, Madrid, Spain",
            "HCU Virgen de la Victoria, Malaga, Spain",
            "Clinica Universitaria de Navarra, Pamplona, Spain",
            "Hospital Mutua de Terrassa, Terrassa (Barcelona), Spain",
            "Hospital Clinico Universitario de Valencia, Valencia, Spain",
            "Hospital Universitario Miguel Servet, Zaragoza, Spain",
            "Lanssjukhuset Ryhov, Jönköping, Sweden",
            "Norrlands Universitetssjukhus, Umeå, Sweden",
            "Centrallasarettet Vasteras, Västerås, Sweden",
            "Clatterbridge Centre for Oncology NHS Trust, Bebington, Wirral, United Kingdom",
            "Addenbrookes Hospital, Cambridge, United Kingdom",
            "Royal Surrey County Hospital, Guildford, United Kingdom",
            "Guy's and St Thomas' Hospital - London, London, United Kingdom",
            "St George's Hospital, London, United Kingdom",
            "Royal Marsden Hospital, London, United Kingdom",
            "Christie NHS Trust Hospital, Manchester, United Kingdom",
            "Nottingham City Hospital, Nottingham, United Kingdom",
            "Northern Lincolnshire and Goole Hospitals NHS Foundation Trust, Scunthorpe, United Kingdom",
            "Royal Marsden Hospital, Sutton, United Kingdom"
          ]
        },
        "url": "https://ClinicalTrials.gov/show/NCT00988208"
      },
      {
        "-rank": "150",
        "nct_id": "NCT02730338",
        "title": "INTense Exercise foR surVivAL Among Men With Metastatic Castrate-Resistant Prostate Cancer",
        "acronym": "INTERVAL",
        "status": {
          "-open": "Y",
          "#text": "Recruiting"
        },
        "study_results": "No Results Available",
        "conditions": { "condition": "Prostate Cancer Metastatic" },
        "interventions": {
          "intervention": [
            {
              "-type": "Behavioral",
              "#text": "High intensity aerobic and resistance training"
            },
            {
              "-type": "Behavioral",
              "#text": "Psychosocial support"
            }
          ]
        },
        "outcome_measures": {
          "outcome_measure": [
            "Overall Survival",
            "Disease Progression",
            "Symptomatic Skeletal Related Events (SSE)",
            "Opiate Use",
            "Analgesic Use",
            "Biomarker analysis",
            "Quality of Life",
            "Physical Function",
            "Pain"
          ]
        },
        "sponsors": {
          "lead_sponsor": "Movember Foundation",
          "collaborator": [
            "University of California, San Francisco",
            "Edith Cowan University",
            "King's College London",
            "Centre hospitalier de l'Université de Montréal (CHUM)",
            "Epworth Foundation"
          ]
        },
        "gender": "Male",
        "min_age": "18 Years",
        "age_groups": {
          "age_group": [
            "Adult",
            "Older Adult"
          ]
        },
        "phases": { "phase": "Not Applicable" },
        "enrollment": "866",
        "funded_bys": { "funded_by": "Other" },
        "study_types": "Interventional",
        "study_designs": {
          "study_design": [
            "Allocation: Randomized",
            "Intervention Model: Parallel Assignment",
            "Masking: None (Open Label)",
            "Primary Purpose: Treatment"
          ]
        },
        "other_ids": { "other_id": "GAP4" },
        "start_date": "January 2016",
        "primary_completion_date": "October 2024",
        "completion_date": "October 2024",
        "study_first_posted": "April 6, 2016",
        "last_update_posted": "June 28, 2019",
        "locations": {
          "location": [
            "Cedars Sinai Medical Centre, Los Angeles, California, United States",
            "UCSF, San Francisco, California, United States",
            "UC Denver, Denver, Colorado, United States",
            "University of Minnesota, Minneapolis, Minnesota, United States",
            "Oregon Health & Science University, Portland, Oregon, United States",
            "Fred Hutchinson Cancer Centre, Seattle, Washington, United States",
            "Australian Prostate Cncr Research Centre, Brisbane, Queensland, Australia",
            "GenesisCare Wesley, Brisbane, Queensland, Australia",
            "University of Queensland, Brisbane, Queensland, Australia",
            "Epworth Hospital, Melbourne, Victoria, Australia",
            "Victoria University / Sunshine Hospital, Melbourne, Victoria, Australia",
            "Edith Cowan University, Perth, Western Australia, Australia",
            "University of Alberta, Edmonton, Alberta, Canada",
            "QEII Cancer Centre / Dalhousie University, Halifax, Nova Scotia, Canada",
            "Princess Margaret Cancer Centre, Toronto, Ontario, Canada",
            "Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Canada",
            "West China Hospital of Sichuan University, Chengdu, China",
            "German Sport University Cologne, Cologne, Germany",
            "Trinity University, Dublin, Ireland",
            "Erasmus MC, Rotterdam, Netherlands",
            "University of Surrey, Guildford, Surrey, United Kingdom",
            "University of Bath / Bath Royal United Hospital, Bath, United Kingdom",
            "Queen's University Belfast, Belfast, United Kingdom",
            "University of Glasgow, Glasgow, United Kingdom",
            "Kings College London, London, United Kingdom"
          ]
        },
        "url": "https://ClinicalTrials.gov/show/NCT02730338"
      },
      {
        "-rank": "151",
        "nct_id": "NCT01226576",
        "title": "Focal MR-Guided Focused Ultrasound Treatment of Localized Low-Intermediate Risk Prostate Cancer: Feasibility Study",
        "status": {
          "-open": "N",
          "#text": "Completed"
        },
        "study_results": "No Results Available",
        "conditions": { "condition": "Localized Low-Intermediate Risk Prostate Cancer" },
        "interventions": {
          "intervention": {
            "-type": "Device",
            "#text": "MRgFUS Treatment"
          }
        },
        "outcome_measures": {
          "outcome_measure": [
            "Safety and initial Effectiveness",
            "Safety",
            "Effectiveness",
            "QOL"
          ]
        },
        "sponsors": { "lead_sponsor": "InSightec" },
        "gender": "Male",
        "min_age": "50 Years",
        "max_age": "75 Years",
        "age_groups": {
          "age_group": [
            "Adult",
            "Older Adult"
          ]
        },
        "phases": { "phase": "Not Applicable" },
        "enrollment": "8",
        "funded_bys": { "funded_by": "Industry" },
        "study_types": "Interventional",
        "study_designs": {
          "study_design": [
            "Intervention Model: Single Group Assignment",
            "Masking: None (Open Label)",
            "Primary Purpose: Treatment"
          ]
        },
        "other_ids": { "other_id": "PCa004" },
        "start_date": "October 2010",
        "primary_completion_date": "December 2018",
        "completion_date": "December 2018",
        "study_first_posted": "October 22, 2010",
        "last_update_posted": "March 13, 2019",
        "locations": {
          "location": [
            "University Health Network, Toronto, Ontario, Canada",
            "Sheba Medical Center, Tel Hashomer, Israel",
            "Sapienza University Hospital, Rome, Italy",
            "National Cancer Center Singapore, Singapore, Singapore",
            "St. Mary's Hospital, London, United Kingdom"
          ]
        },
        "url": "https://ClinicalTrials.gov/show/NCT01226576"
      },
      {
        "-rank": "152",
        "nct_id": "NCT00974311",
        "title": "Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy",
        "acronym": "AFFIRM",
        "status": {
          "-open": "N",
          "#text": "Completed"
        },
        "study_results": "Has Results",
        "conditions": { "condition": "Castration-Resistant Prostate Cancer" },
        "interventions": {
          "intervention": [
            {
              "-type": "Drug",
              "#text": "Enzalutamide"
            },
            {
              "-type": "Drug",
              "#text": "Placebo"
            }
          ]
        },
        "outcome_measures": {
          "outcome_measure": [
            "Overall Survival",
            "Radiographic Progression-free Survival",
            "Time to First Skeletal-related Event",
            "Percentage of Participants Who Were Responders for Functional Assessment of Cancer Therapy-Prostate (FACT-P)",
            "Time to Prostate-specific Antigen (PSA) Progression",
            "Percentage of Participants With Pain Palliation",
            "Percentage of Participants With Prostate Specific Antigen (PSA) Response",
            "Percentage of Participants With Soft-tissue Objective Response",
            "European Quality of Life Five-Domain (EQ-5D) Scale",
            "Percentage of Participants With Circulating Tumor Cell (CTC) Conversion"
          ]
        },
        "sponsors": {
          "lead_sponsor": "Pfizer",
          "collaborator": [
            "Astellas Pharma Inc",
            "Medivation LLC, a wholly owned subsidiary of Pfizer Inc."
          ]
        },
        "gender": "Male",
        "min_age": "18 Years",
        "age_groups": {
          "age_group": [
            "Adult",
            "Older Adult"
          ]
        },
        "phases": { "phase": "Phase 3" },
        "enrollment": "1199",
        "funded_bys": { "funded_by": "Industry" },
        "study_types": "Interventional",
        "study_designs": {
          "study_design": [
            "Allocation: Randomized",
            "Intervention Model: Parallel Assignment",
            "Masking: Triple (Participant, Investigator, Outcomes Assessor)",
            "Primary Purpose: Treatment"
          ]
        },
        "other_ids": {
          "other_id": [
            "CRPC2",
            "2009-013174-41",
            "C3431010"
          ]
        },
        "start_date": "September 30, 2009",
        "primary_completion_date": "September 15, 2011",
        "completion_date": "November 2, 2017",
        "study_first_posted": "September 10, 2009",
        "results_first_posted": "October 30, 2012",
        "last_update_posted": "December 11, 2018",
        "locations": {
          "location": [
            "University of Alabama at Birmingham, Birmingham, Alabama, United States",
            "University of Alabama at Birmingham, Birmingham, Alabama, United States",
            "Mayo Clinic Hospital, Phoenix, Arizona, United States",
            "Premiere Oncology of Arizona, Scottsdale, Arizona, United States",
            "Mayo Clinic Arizona, Scottsdale, Arizona, United States",
            "Tower Cancer Research Foundation, Tower Hematology Oncology Medical Group, Beverly Hills, California, United States",
            "USC Westside Prostate Cancer Center, Beverly Hills, California, United States",
            "City of Hope, Duarte, California, United States",
            "Cancer Center Oncology Medical Group, La Mesa, California, United States",
            "LAC & USC Medical Center, Los Angeles, California, United States",
            "USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States",
            "Ronald Reagan UCLA Medical Center, Los Angeles, California, United States",
            "UCLA, Los Angeles, California, United States",
            "c/o Prostate Oncology Specialist, Inc., Marina Del Rey, California, United States",
            "North County Oncology Medical Clinic, Inc,, Oceanside, California, United States",
            "Medical Oncology Associates - SD, San Diego, California, United States",
            "Sharp Memorial Hospital Investigational Pharmacy, San Diego, California, United States",
            "Sharp Rees-Stealy, San Diego, California, United States",
            "UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States",
            "City of Hope Medical Group, South Pasadena, California, United States",
            "Stanford Hospital and Clinics Research Pharmacy, Stanford, California, United States",
            "Stanford University Medical Center, Stanford, California, United States",
            "Research Pharmacist, Aurora, Colorado, United States",
            "University of Colorado Denver, Anschutz Cancer Pavilion, Aurora, Colorado, United States",
            "C/O: Thomas Ferencz R.Ph., BCOP, New Haven, Connecticut, United States",
            "Yale University School of Med, New Haven, Connecticut, United States",
            "George Washington University-Medical Faculty Associates, Washington, District of Columbia, United States",
            "Palm Beach Cancer Institute, Atlantis, Florida, United States",
            "Palm Beach Cancer Institute, Palm Beach Gardens, Florida, United States",
            "Palm Beach Cancer Institute, Wellington, Florida, United States",
            "Palm Beach Cancer Institute, West Palm Beach, Florida, United States",
            "Peachtree Hematology-Oncology Consultants, P.C., Atlanta, Georgia, United States",
            "University of Chicago Medical Center, Chicago, Illinois, United States",
            "University of Chicago, Chicago, Illinois, United States",
            "The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States",
            "The Johns Hopkins Hospital, Baltimore, Maryland, United States",
            "Massachusetts General Hospital (MGH), Boston, Massachusetts, United States",
            "Brigham & Women's Hospital (BWH), Boston, Massachusetts, United States",
            "Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States",
            "Dana-Farber Cancer Institute, Boston, Massachusetts, United States",
            "Karmanos Cancer Institute, Detroit, Michigan, United States",
            "Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States",
            "Mayo Clinic, Rochester, Minnesota, United States",
            "Siteman Cancer Center-West County, Creve Coeur, Missouri, United States",
            "Barnes-Jewish Hospital, Saint Louis, Missouri, United States",
            "Washington University School of Medicine, Saint Louis, Missouri, United States",
            "Siteman Cancer Center, Saint Peters, Missouri, United States",
            "Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States",
            "Nevada Cancer Institute, an affiliate of the UC San Diego Health System, Las Vegas, Nevada, United States",
            "Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States",
            "New Mexico Oncology Hematology Consultants, Ltd., Albuquerque, New Mexico, United States",
            "Roswell Park Cancer Institute, Buffalo, New York, United States",
            "Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York, United States",
            "Memorial Sloan-Kettering Cancer Center, New York, New York, United States",
            "Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York, United States",
            "Duke University Medical Center, Durham, North Carolina, United States",
            "Pharmaceutical Research Services, Durham, North Carolina, United States",
            "Portland VA Medical Center, Portland, Oregon, United States",
            "UPMC Cancer Centers, McKeesport, Pennsylvania, United States",
            "Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States",
            "Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States",
            "University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States",
            "UPMC Cancer Centers, Pittsburgh, Pennsylvania, United States",
            "VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States",
            "Hollings Cancer Center, Charleston, South Carolina, United States",
            "Medical University of South Carolina (MUSC), Charleston, South Carolina, United States",
            "Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States",
            "Grand Strand Urology, Myrtle Beach, South Carolina, United States",
            "Tennessee Oncology, PLLC, Chattanooga, Tennessee, United States",
            "Tennessee Oncology, PLLC, Dickson, Tennessee, United States",
            "Tennessee Oncology, PLLC, Franklin, Tennessee, United States",
            "Tennessee Oncology, PLLC, Gallatin, Tennessee, United States",
            "Tennessee Oncology, PLLC, Hermitage, Tennessee, United States",
            "Tennessee Oncology, PLLC, Lebanon, Tennessee, United States",
            "Tennessee Oncology, PLLC, Murfreesboro, Tennessee, United States",
            "Tennessee Oncology, PLLC, Nashville, Tennessee, United States",
            "The Sarah Cannon Research Institute, Nashville, Tennessee, United States",
            "Tennessee Oncology, PLLC, Nashville, Tennessee, United States",
            "Tennessee Oncology, PLLC, Nashville, Tennessee, United States",
            "Tennessee Oncology, PLLC, Nashville, Tennessee, United States",
            "Vanderbilt University Medical Center, Nashville, Tennessee, United States",
            "Tennessee Oncology, PLLC, Smyrna, Tennessee, United States",
            "Parkland Health and Hospital System, Dallas, Texas, United States",
            "Texas Oncology, Sammons Cancer Center, Dallas, Texas, United States",
            "UT Southwestern Medical Center at Dallas, Dallas, Texas, United States",
            "Virginia Oncology Associates, Chesapeake, Virginia, United States",
            "Virginia Oncology Associates, Hampton, Virginia, United States",
            "Virginia Cancer Institute, Mechanicsville, Virginia, United States",
            "Virginia Cancer Institute, Midlothian, Virginia, United States",
            "Virginia Oncology Associates, Newport News, Virginia, United States",
            "Virginia Oncology Associates, Norfolk, Virginia, United States",
            "Virginia Cancer Institute, Richmond, Virginia, United States",
            "Virginia Cancer Institute, Richmond, Virginia, United States",
            "Virginia Oncology Associates, Virginia Beach, Virginia, United States",
            "Virginia Oncology Associates, Williamsburg, Virginia, United States",
            "Seattle Cancer Care Alliance, Seattle, Washington, United States",
            "University of Washington Medical Center, Seattle, Washington, United States",
            "University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States",
            "Instituto Medico de Asistencia e Investigaciones S.A (IMAI Research), Buenos Aires, AR, Argentina",
            "Instituto Oulton, Cordoba, Provincia DE Cordoba, Argentina",
            "Clinica Universitaria Privada Reina Fabiola, Cordoba, Provincia DE Cordoba, Argentina",
            "Policlinico Neuquen, Neuquen, Provincia DE Neuquen, Argentina",
            "Policlinico Modelo de Cipolletti, Cipolletti, Provincia DE RIO Negro, Argentina",
            "Instituto de Investigaciones Clinicas Cipolletti, Cipolletti, Provincia DE RIO Negro, Argentina",
            "Sanatorio Mapaci, Rosario, Provincia DE Santa FE, Argentina",
            "Instituto de Oncologia y Especialidades Medicas, Rosario, Provincia DE Santa FE, Argentina",
            "Hospital Italiano Garibaldi, Rosario, Provincia DE Santa FE, Argentina",
            "Centro de Diagnostico Dr. Enrique Rossi, Ciudad Autonoma de Buenos Aires, Argentina",
            "Centro de Diagnostico Dr. Enrique Rossi, Ciudad Autonoma de Buenos Aires, Argentina",
            "North Coast Cancer Institute, Coffs Harbour, New South Wales, Australia",
            "Sydney Cancer Centre, Concord, New South Wales, Australia",
            "Mid North Coast Diagnostic Imaging, Port Macquarie, New South Wales, Australia",
            "Port Macquarie Base Hospital Pharmacy, Port Macquarie, New South Wales, Australia",
            "Port Macquarie Base Hospital, Port Macquarie, New South Wales, Australia",
            "Prince of Wales Hospital, Department of Medical Oncology, Randwick, New South Wales, Australia",
            "The Tweed Hospital, Tweed Heads, New South Wales, Australia",
            "PRP Diagnostic Imaging, Wentworthville, New South Wales, Australia",
            "Sydney West Cancer Trials Centre, Department of Medical Oncology, Westmead, New South Wales, Australia",
            "River City Pharmacy, Auchenflower, Queensland, Australia",
            "Heart Care Partners, Auchenflower, Queensland, Australia",
            "Icon Cancer Care Wesley, Auchenflower, Queensland, Australia",
            "Icon Cancer Care Chermside, Chermside, Queensland, Australia",
            "Southern X-Ray Chermside, Chermside, Queensland, Australia",
            "Cancer Care Services, Herston, Queensland, Australia",
            "Icon Cancer Foundation, Milton, Queensland, Australia",
            "Icon Cancer Care South Brisbane, South Brisbane, Queensland, Australia",
            "Mater Private Cardiology, South Brisbane, Queensland, Australia",
            "Queensland X-Ray, South Brisbane, Queensland, Australia",
            "XRadiology, Toowong, Queensland, Australia",
            "Department of Medical Oncology, Adelaide, South Australia, Australia",
            "Royal Hobart Hospital, Hobart, Tasmania, Australia",
            "St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia",
            "Peninsula Oncology Centre, Frankston, Victoria, Australia",
            "Austin Hospital, Heidelberg, Victoria, Australia",
            "Sir Charles Gairdner Hospital, Department of Medical Oncology, Nedlands, Western Australia, Australia",
            "60 Eleanor St, Footscray, Australia",
            "Western Hospital, Footscray, Australia",
            "The Royal Melbourne Hospital, Victoria, Australia",
            "Krankenhaus der Barmherzigen Schwestern Linz, Linz, Austria",
            "ISOTOPIX Ambulatorium fuer, Vienna, Austria",
            "Medical University of Vienna, Vienna, Austria",
            "Cliniques Universitaires Saint- Luc, Brussels, Belgium",
            "AZ Sint- Lucas, Ghent, Belgium",
            "VZW Jessa Ziekenhuis, Hasselt, Belgium",
            "AZ Groeninge - Campus Kennedylaan, Kortrijk, Belgium",
            "AZ Groeninge - Campus Sint Maarten, Kortrijk, Belgium",
            "University Hospital Gasthuisberg, Leuven, Belgium",
            "H.-Hartziekenhuis Roeselare-Menen vzw, Roeselare, Belgium",
            "Tom Baker Cancer Centre, Calgary, Alberta, Canada",
            "Tom Baker Cancer Centre - Holy Cross Site, Calgary, Alberta, Canada",
            "Cross Cancer Institute, Edmonton, Alberta, Canada",
            "British Columbia Cancer Agency, Centre for the Southern Interior, Kelowna, British Columbia, Canada",
            "B.C. Cancer Agency - Vancouver Centre, Vancouver, British Columbia, Canada",
            "British Columbia Cancer Agency - Vancouver Island Centre, Victoria, British Columbia, Canada",
            "QEII Health Sciences Centre, Halifax, Nova Scotia, Canada",
            "QEII Health Sciences Centre, Halifax, Nova Scotia, Canada",
            "QEII Health Sciences Centre, Halifax, Nova Scotia, Canada",
            "Juravinski Cancer Centre, Hamilton, Ontario, Canada",
            "London Regional Cancer Program, London, Ontario, Canada",
            "Princess Margaret Hospital, Toronto, Ontario, Canada",
            "Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada",
            "The Urology Specialists., Montreal, Quebec, Canada",
            "Imagerie medicale de la Capitale, Quebec, Canada",
            "CHU de Quebec, Quebec, Canada",
            "Centre de rechereche clinique et evaluative en oncologie, Quebec, Canada",
            "Hospital San Jose, Santiago, Chile",
            "Instituto Nacional del Cancer, Santiago, Chile",
            "Centro Investigacion Clinica del Sur, Temuco, Chile",
            "Instituto Oncologico, Vina del Mar, Chile",
            "Centre Paul Papin, Angers Cedex 9, France",
            "Institut Bergonie, Bordeaux cedex, France",
            "Centre Regional Francois Baclesse de lutte contre le cancer, Caen Cedex, France",
            "Centre hospitalier de Cannes, Cannes Cedex, France",
            "CHU Henri Mondor, Creteil, France",
            "Centre Hospitalier Intercommunal Frejus-Saint Raphael, Frejus Cedex, France",
            "Centre hospitalier departemental Vendee, LA Roche sur Yon, France",
            "Clinique Victor Hugo - Centre Jean Bernard, Le Mans, France",
            "Centre Leon Berard, Lyon Cedex 08, France",
            "Groupement Hospitalier Edouard Herriot - Pavillon V, Lyon Cedex 3, France",
            "Institut Paoli Calmettes, Marseille, France",
            "Institut Curie, Paris, France",
            "Hopital Europeen Georges Pompidou, Paris, France",
            "Centre Hospitalier Lyon sud, Pierre Benite, France",
            "CHU La Miletrie, Poitiers Cedex, France",
            "Institut Jean Godinot, Reims Cedex, France",
            "Centre Hospitalier, Saint Etienne Cedex 2, France",
            "Institut de Cancerologie de la Loire, Saint Priest en Jarez, France",
            "Centre d'Investigation Clinique, (CIE3), Saint-Etienne CEDEX 2, France",
            "Centre Rene Gauducheau, SAINT-HERBLAIN Cedex, France",
            "Hopital Foch, Suresnes Cedex, France",
            "Institut Gustave Roussy, Villejuif, France",
            "Universitaetsklinikum Aachen, Aachen, Germany",
            "Charite - Universitaetsmedizin Berlin-Campus Benjamin Franklin, Berlin, Germany",
            "Gemeinschaftspraxis Fuer Nuklearmedizin, Berlin, Germany",
            "Radiologische Gemeinschaftspraxis, Berlin, Germany",
            "FacharztzentrumInnere Medizin, Berlin, Germany",
            "Praxis Dr. Wolfgang Hoelzer, Berlin, Germany",
            "Staedtisches Klinikum Braunschweig gGmbH, Braunschweig, Germany",
            "Technical University Dresden, Dresden, Germany",
            "Martini-Klinik am UKE GmbH, Hamburg, Germany",
            "Roentgenpraxis, Hamburg, Germany",
            "Urologische Gemeinschaftspraxis Poppenbuettel, Hamburg, Germany",
            "Medizinische Hochschule Hannover - Klinik fuer Urologie und Urologische Onkologie, Hannover, Germany",
            "Medizinische Hochschule Hannover, Hannover, Germany",
            "Universitaetsklinikum Heidelberg, Heidelberg, Germany",
            "Universitaetsklinikum Mannheim, Mannheim, Germany",
            "Universitaetsklinikum Muenster, Klinik fuer Klinische Radiologie, Muenster, Germany",
            "Universitaetsklinikum Muenster, Klinik und Poliklinik fuer Nuklearmedizin, Muenster, Germany",
            "Universitaetsklinikum Muenster, Klinik und Poliklinik fuer Urologie, Muenster, Germany",
            "Abt.f.Diagnostische u. Interventionelle Radiologie, Tuebingen, Germany",
            "Klinik fuer Urologie, Tuebingen, Germany",
            "Nuklearmedizin, Tuebingen, Germany",
            "Azienda Ospedaliero-Universitaria di Modena Policlinico, Via Del Pozzo 71, Modena, Italy",
            "Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano, TO, Italy",
            "Azienda Ospedaliera \"Istituti Ospitalieri\" di Cremona, Cremona, Italy",
            "Azienda Ospedaliera San Camillo Forlanini, Rome, Italy",
            "VU Medisch Centrum, Amsterdam, Netherlands",
            "UMC St. Radboud, Nijmegen, Netherlands",
            "Erasmus MC, Rotterdam, Netherlands",
            "Uniwersyteckie Centrum Kliniczne, Gdansk, Poland",
            "Regionalny Szpital Specjalistyczny im. Dr. Wladyslawa Bieganskiego, Grudziadz, Poland",
            "Wojewodzki Szpital Specjalistyczny im. M. Kopernika, Regionalny Osrodek Onkologiczny, Lodz, Poland",
            "Wojewodzki Szpital Specjalistyczny im. M. Kopernika, Lodz, Poland",
            "Wojewodzki szpital specjalistyczny im. Janusza Korczaka, Slupsk, Poland",
            "Hopelands Cancer Centre, Durban, South Africa",
            "GVI Oncology, Port Elizabeth, South Africa",
            "Sandton Oncology Centre, Sandton, South Africa",
            "Hospital Universitario Germans Trias i Pujol, Badalona, Spain",
            "Hospital del Mar, Barcelona, Spain",
            "Radiodiagnostic Cetir Clinica Pilar, Barcelona, Spain",
            "Hospital Santa Creu i Sant Pau, Barcelona, Spain",
            "Hospital Vall d'Hebron, Barcelona, Spain",
            "Hospital Madrid Norte Sanchinarro, Madrid, Spain",
            "Clinica Universidad de Navarra, Pamplona, Spain",
            "Bishops Wood Hospital, Northwood, Middlesex, United Kingdom",
            "Mount Vernon Hospital, Northwood, Middlesex, United Kingdom",
            "The Royal Marsden Hospital, Sutton, Surrey, United Kingdom",
            "Belfast City Hospital, Belfast, United Kingdom",
            "Cancer Centre, Birmingham, United Kingdom",
            "Bristol Haematology & Oncology Centre, Bristol, United Kingdom",
            "Bristol Royal Infirmary, Bristol, United Kingdom",
            "Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom",
            "The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom",
            "University College Hospital, London, United Kingdom",
            "Hammersmith Hospital, London, United Kingdom",
            "The Christie NHS Foundation Trust, Manchester, United Kingdom",
            "Northern Centre for Cancer Care, Newcastle upon Tyne, United Kingdom",
            "Churchill Hospital, Oxford, United Kingdom",
            "The Manor Hospital Oxford, Oxford, United Kingdom"
          ]
        },
        "url": "https://ClinicalTrials.gov/show/NCT00974311"
      }
    }